Lane Medical Library

search help »

Books by Subject

Oncology

  • Pineal region tumors 2009, Karger
    Statistical analysis of pineal tumors based on the data of brain tumor registry of Japan / Shibui, S., Nomura, K. -- Pathology of pineal parenchymal tumors / Sato, K., Kubota, T. -- Occipital transtentorial approach and combined treatments for pineal parenchymal tumors / Tsumanuma, I., Tanaka, R., Fujii, Y. -- Role of stereotactic radiosurgery in the management of pineal parenchymal tumors -- Kano, H. ... [et al.] -- Pathology of intracranial germ cell tumors / Sato, K., Takeuchi, H., Kubota, T. -- Pineal germ cell tumors / Matsutani, M. -- Strategy of combined treatment of germ cell tumors / Sawamura, Y. -- Radiation therapy for intracranial germ cell tumors / Aoyama, H. -- Stereotactic radiosurgery for pineal and related tumors / Mori, Y. ... [et al.] -- Management of central nervous system germinoma : proposal for a modern strategy / Shibamoto, Y. -- Quality of life of extremely long-time germinoma survivors mainly treated with radiotherapy / Sugiyama, K. ... [et al.].
  • Plants that fight cancer 2004, CRCnetBASE
  • Polyploidy, aneuploidy, and the evolution of cancer / Lauren M.F. Merlo ... [et al.] -- Molecular mechanisms and function of the spindle checkpoint : a guardian of the chromosome stability / Daisuke Ito and Tomohiro Matsumoto -- Understanding cytokinesis failure / Guillaume Normand and Randall W. King -- DNA damage and polyploidization / Jeremy P.H. Chow and Randy Y.C. Poon -- Role of the p53 family in stabilizing the genome and preventing polyploidization / Flaminia Talos and Ute M. Moll -- Centrosomes, polyploidy, and cancer / Anette Duensing and Stefan Duensing -- Polyploidy : mechanisms and cancer promotion in hematopoietic and other cells / Hao G. Nguyen and Katya Ravid -- Polyploidization of liver cells / Séverine Celton-Morizur and Chantal Desdouets -- Analysis of cellular DNA content by flow and laser scanning cytometry / Zbigniew Darzynkiewicz, H. Dorota Halicka, and Hong Zhao.
  • This handbook, written in a clear and precise style, describes the principles of positron emission tomography (PET) and provides detailed information on its application in clinical practice. The first part of the book explains the physical and biochemical basis for PET and covers such topics as instrumentation, image reconstruction, and the production and diagnostic properties of radiopharmaceuticals. The focus then turns to the use of PET in clinical practice, including its role in hybrid imaging (PET-CT). A wide range of oncological applications are discussed, including for cancers of the head and neck, breast, lung, digestive system, urinary tract, female reproductive system, and prostate, lymphoproliferative disorders, melanoma, and musculoskeletal tumors. Uses of PET in cardiology, neurology, and psychiatry are also addressed. Characteristic findings are described and illustrated by numerous images, many of them in color. This book will be of value not only for nuclear medicine physicians and radiologists but also for all oncologists, surgeons, cardiologists, neurologists, psychiatrists, and residents with an interest in molecular imaging.
  • An overview of the management of thyroid cancer -- The UK evidence-based guidelines for the management of thyroid cancer: key recommendations -- Thyroid cancer multidisciplinary team and the organisational paradigm -- Thyroid cancer form the perspective of a patient -- The role of the specialist nurse -- The role of the clinical psychologist -- Thyroid nodules -- Thyroid cancer and the general practitioner -- The role of pathologist -- Thyroid cancer and the endocrinologist -- The specialist endocrine surgeon -- Initial thyroid surery for patient with differentiated thyroid carcinoma -- Management of cervical lymph nodes in differentiated thyroid cancer -- Complications of thyroid surgery -- Non-surgical management of thyroid cancer -- Fertility following treatment with iodine-131 for thyroid cancer -- Recombinant human TSH (rhTSH): use in papillary and follicular thyroid cancer -- Thyroglobulin -- Follow-up of patients with differentiated thyroid carcinoma --- Management of differentiated thyroid carcinoma patients with negative whole-body radioiodine scans and elevated serum thyroglobulin levels -- Medullary thyroid cancer: diagnosis and management -- Nonmedullary thyroid cancer and the role of the geneticist -- Thyroid cancer in childhood -- Radiation-induced thyroid cancer: lessons from Chernobyl -- The use of stable potassium iodide (KI) in the event of a nuclear emergency -- Ultrasound of the thyroid -- Diagnostic nuclear medicine investigations in the management of thyroid cancer -- CT and MRI in thyroid cancer -- Papillary microcarcinoma of the thyroid -- Rare thyroid cancers -- Management of anaplastic thyroid cancer -- Specialist palliative care for anaplastic thyroid carcinoma -- Emerging therapies for thyroid cancer -- Clinical trials for thyroid carcinoma: past, present, and future.
  • Pre-invasive disease 2011, Springer
  • Overview of the topic -- Meaning of SPC -- Importance of SPC -- Framework and methodology -- Lymphomas -- Leukemias -- Breast cancer (female) -- Lung cancer -- Cancers of the head and neck -- Gastrointestinal cancers -- Genitourinary cancers -- Gynecologic cancers -- Skin cancers -- Pediatric cancers -- Summary of significant SPC associations -- Population health priorities.
  • Epidemiology and risk factors -- Molecular pathogenesis -- Cellular origins of malignant glioma: the cancer stem cell polemic -- Principles of supportive care -- Principles of clinical trial design and response assessment -- Complications of therapy -- Neuropsychological function and quality of life -- Low-grade gliomas -- High-grade astrocytomas -- Anaplastic oligodendrogliomas and mixed gliomas -- Ependymomas -- Uncommon gliomas in adults: brainstem gliomas, pilocytic astrocytomas, and pleomorphic xanthastrocytomas -- Pediatric tumors -- Primary central nervous system lymphoma -- Meningiomas -- Pituitary adenomas -- Vestibular schwannomas -- Medulloblastomas -- Pineal region tumors -- Genetic syndromes -- Rare tumors -- Spinal tumors.
  • Primary liver cancer 2012, Springer
  • Primary liver cancer 2012, Springer
  • Primo vascular system 2012, Springer
  • Infections in patients with cancer : overview / Amar Safdar, Gerald Bodey, and Donald Armstrong -- Infections in hematopoietic stem cell transplant recipients / Georg Maschmeyer and Per Ljungman -- Infections in patients with hematologic malignancies / Genovefa Papanicolaou and Jayesh Mehta -- Infections in solid tumor patients / Alison G. Freifeld -- Infections in patients with hematologic malignancies treated with monoclonal antineoplastic therapy / André Goy and Susan O'Brien -- Postsurgery infections in cancer patients / Emilio Bouza ... [et. al] -- Management of infections in critically ill cancer patients / Henry Masur -- Management of the neutropenic patient with fever / Kenneth V. I. Rolston and Gerald P. Bodey -- Controversies in empiric therapy of febrile neutropenia / John R. Wingard -- Catheter-related infections in cancer patients / Iba Al Wohoush, Anne-Marie Chaftari, and Issam Raad -- Intravascular device-related infections : catheter salvage strategies and prevention of device-related infection / Nasia Safdar and Dennis G. Maki -- Pneumonia in the cancer patient / Scott E. Evans and Amar Safdar -- Noninfectious lung infiltrates that may be confused with pneumonia in the cancer patient / Rana Kaplan ... [et. al] -- Mucosal barrier injury and infections / Nicole M. A. Blijlevens and J. Peter Donnelly -- Bacterial colonization and host immunity / Coralia N. Mihu, Karen J. Vigil, and Javier A. Adachi -- Neutropenic enterocolitis and clostridium difficile infections / Amar Safdar ... [et. al] -- Management of reactivation of hepatitis B and hepatitis C during antineoplastic therapy / Marta Davila and Harrys A. Torres -- Management of genitourinary tract infections / Amar Safdar and Maurie Markman -- Central nervous system infections in cancer patients / Victor Mulanovich and Amar Safdar -- Endocarditis in oncology patients / Sara E. Cosgrove and Aruna Subramanian -- Skin disorders difficult to distinguish from infections / Sharone Hymes, Susan Chon, and Ana Ciurea -- Overview of invasive fungal disease in oncology patients / Amar Safdar -- Diagnosis of invasive fungal disease / Dionissios Neofytos and Kieren Marr -- Invasive candidiasis in management of infections in cancer patients / Matteo Bassetti ... [et. al] -- Management of aspergillosis, zygomycosis, and other clinically relevant mold infections / Konstantinos Leventakos and Dimitrios P. Kontoyiannis -- Cryptococcal disease and endemic mycosis / Johan A. Maertens and Hélène Schoemans -- Current controversies in the treatment of fungal infections / Christopher D. Pfeiffer, John R. Perfect, and Barbra D. Alexander --Fungal drug resistance and pharmacologic considerations of dosing newer antifungal therapies / Russell E. Lewis and David S. Perlin -- Immunotherapy for difficult-to-treat invasive fungal diseases / Brahm H. Segal, Amar Safdar, and David A. Stevens -- Cytomegalovirus in patients with cancer / Morgan Hakki, Per Ljungman, and Michael Boeckh -- Epstein-Barr virus, varicella zoster virus, and human herpes viruses-6 and -8 / Mini Kamboj and David M. Weinstock -- Respiratory viruses / Roy F. Chemaly, Dhanesh B. Rathod, and Robert Couch -- BK, JC and parvovirus infections in patients with hematologic malignancies / Véronique Erard and Michael Boeckh -- Antiviral resistance and implications for prophylaxis / Robin K. Avery -- Management of gram-positive bacterial disease : staphylococcus aureus, streptococcal, pneumococcal, and enterococcal infections / Samuel Shelburne and Daniel M. Musher -- Infections caused by aerobic and anaerobic gram-negative bacilli / Kenneth V. I. Rolston, David E.Greenberg, and Amar Safdar -- Listeriosis and nocardiosis / Heather E. Clauss and Bennett Lorber -- Antibacterial distribution and drug-drug interactions in cancer patients / Ursula Theuretzbacher and Markus Zeitlinger -- Mycobacterium tuberculosis infection / Michael Glickman -- Nontuberculous mycobacterial infections / Amar Safdar -- Parasitic infections in cancer patients : toxoplasmosis, strongyloidiasis and other parasites / Brian G. Blackburn and José G. Montoya -- Zoonoses in cancer patients / Donald Armstrong -- Antibiotic stewardship : considerations for a cancer Center / Coralia N. Mihu, Alla Paskovaty, and Susan K. Seo -- Controversies in antimicrobial stewardship / Graeme N. Forrest -- Prevention of antimicrobial resistance : current and future strategies / Cesar A. Arias and Adolf W. Karchmer -- Antibacterial, antifungal, and antiviral prophylaxis / Marcio Nucci and John R. Wingard -- Controversies in antimicrobial prophylaxis / Ben de Pauw and Marta Stanzani -- Infection prevention : protected environment and infection control / J. Peter Donnelly -- Prevention of tropical and parasitic infections : the immunocompromised traveler / Francesca F. Norman and Rogelio López-Vélez -- Prophylactic vaccination of cancer patients and hematopoietic stem cell transplant recipients / William Decker and Amar Safdar.
  • Gastrointestinal cancer: epidemioloy -- Gastrointestinal cancer: pathology and molecular pathology -- Gastrointestinal cancer: cancer genetics -- Gastrointestinal cancer: screening and surveillance -- Gastrointestinal cancer: surgical oncology -- Gastrointestional cancer management: biological aspects of radiation therapy -- Gastrointestinal cancer: medical oncology -- Gastrointestinal cancer: nutritional support -- Imaging of gastrointestinal malignancies -- Endoscopic diagnosis, staging, and management of gastrointestinal cancers -- An overview of outcomes research in gastrointestinal cancer -- Integrative oncology: complementary therapies in gastrointestinal cancer care -- Pain and symptom control -- Esophageal cancer: epidemiology, screening, and prevention -- The molecular genetics of esophageal cancer -- Esophageal cancer: pathology -- Esophageal cancer: anatomy and staging -- Esophageal cancer: clinical management -- Gastric cancer: epidemiology, screening, surveillance, and prevention -- Gastric cancer: molecular biology and genetics -- Gastric cancer: pathology -- Gastric cancer: staging systems and techniques -- Gastric cancer: clinical management -- Pancreas cancer: epidemiology and risk factors -- Pancreatic cancer: molecular biology and genetics -- Pancreas cancer: anatomy, staging systems, and techniques -- Pathology of pancreatic cancer -- Pancreas cancer: clinical management -- Hepatocellular carcinoma: epidemiology, screening and prevention -- Hepatocellular carcinoma: molecular biology and genetics -- Hepatocellular cancer: pathology -- Hepatocellular cancer: anatomy and staging -- Hepatocellular cancer: clinical management -- Cancer of the gallbladder and biliary tree: epidemiology -- Pathology of biliary tract cancer -- Cancers of the biliary tree: anatomy and staging -- Cancers of the biliary tree: clinical management -- Environmental and lifestyle issues in colorectal cancer -- Colorectal cancer: screening and surveillance -- Colorectal cancer: molecular biology and genetics -- Colorectal cancer: pathology -- Colorectal cancer: anatomy and staging -- Colon cancer: management of locoregional disease -- Rectal cancer: management of locoreginal disease -- Systemic therapy for metastatic colorectal cancer -- Colorectal cancer: surgery and local ablation of liver metasteses -- Anal canal cancer -- Neuroendocrine tumors of the gastrointestinal tract -- Lymphomas of the gastrointestinal tract -- Gastrointestinal stromal tumors -- Small bowel cancers -- Cancer of unknown primary site -- Malignant peritoneal mesothelioma.
  • Pt. I. General information -- Epidemiology and etiology of breast cancer -- Staging of breast cancer -- Molecular classification -- Prognostic and predictive factors -- Mechanisms of resistance to radiation -- Interaction of chemotherapy, radiotherapy, and timing -- Interactions of radiotherapy with hormonotherapy -- pt. II. Therapeutic results of radiotherapy in breast cancer -- Ductal carcinoma in situ -- Early stage breast cancer -- Locally advanced breast cancer -- Metastatic breast cancer -- pt. III. Radiotherapy atlas in breast cancer -- The organs at risk and radiation tolerance doses -- Chest wall and regional lymphatics -- Breast and tumor bed -- pt. IV. Modern radiotherapy techniques in breast cancer -- Simulation and patient fixation methods -- Three-dimensional planning techniques -- Inverse planning, intensity modulated radiation therapy, and image-guided radiation therapy -- Forward planning intensity modulated radiation therapy techniques -- Boost techniques -- Quality assurance -- Partial breast irradiation -- Hypofractionation -- Application of tomotherapy in breast cancer patients -- pt. V. Radiotherapy complications in breast cancer -- Radiotherapy complications.
  • Difficult pain syndromes: neuropathic pain, bone pain, and visceral pain -- Opioid pharmacotherapy -- Nonpharmacologic management of pain -- Interventional approaches to pain -- Pathology of bone metastases-implications for treatment -- Pathophysiology of chemotherapy-induced peripheral neuropathy -- Cancer-related fatigue -- Fever and sweats -- Hot flashes -- Anorexia/weight loss -- Dysphagia/speech rehabilitation in palliative care -- Chemotherapy-related nausea and vomiting and treatment-related nausea and vomiting -- Assessment of management of chronic nausea and vomiting -- Diarrhea, malabsorption, and constipation -- Bowel obstruction -- Diagnosis and management of effusions -- Hiccups and other gastrointestinal symptoms -- Biology of treatment-induced mucositis -- Oral manifestations and complications of cancer therapy -- Approach to liver metastases in palliative oncology -- Palliative endoscope procedures -- Palliative interventional radiologic procedures -- Pruritus -- Treatment of tumor-related skin disorders -- Dermatologic adverse events during treatment -- Management of pressure ulcers and fungating wounds -- Lymphedema -- Principles of fistula and stoma management -- Dyspnea in the cancer patient -- Hemoptysis, airway obstruction, bronchospasm, cough, and pulmonary complications/symptoms of cancer and its treatment -- Prevention, assessment, and management of treatment-induced cardiac disease in cancer patients -- Management of hypercoagulable states and coagulopathy -- Urologic issues in palliative care -- Impact of hepatic and renal dysfunction on pharmacology of palliative care drugs -- Hypercalcemia -- Metabolic disorders in the cancer patient -- Infectious complications/management --Management of intracranial metastases -- Management of spinal cord and cauda equina compression -- Recognizing and managing delirium -- Treating depression at the end of life -- Anxiety -- Cognitive decline following cancer treatment -- Substance-abuse issues in palliative care -- Epidemiology and prognostication in advanced cancer -- Hospice -- Cultural issues -- Communication during transitions of care -- The family meetings -- Psychosocial consequences of advanced cancer -- Disorders of sexuality and reproduction -- Caregiving in the home -- Management of symptoms in the actively dying patient -- Spirituality -- Bereavement care -- Staff stress and burnout -- Advance directives, decision making, and withholding and withdrawing treatment -- Palliative care: ethics and the law -- Hematologic support of the cancer patient -- Issues in nutrition and hydration -- Complementary, alternative, and integrative therapies in oncology -- Geriatric palliative care -- Palliative care in pediatrics -- Hematopoietic stem cell transplantation and supportive care -- Long-term survivorship: late effects -- Survivorship issues in adults -- Outcomes assessment in palliative care -- Measurement of quality of life outcomes -- Research issues: ethics and study design.
  • Basic biostatistics for the clinical trialist / Elizabeth G. Hill and Elizabeth Garrett-Mayer -- Fundamental concepts in clinical pharmacology / Daniel L. Gustafson and Erica L. Bradshaw-Pierce -- Bioanalycial methods in clinical drug development / Walter J. Loos, Peter de Bruijn and Alex Sparreboom -- Preclinical models for anticancer drug development / Edward A. Sausville -- Phase I clinical trials with anticancer agents / Stephen Leong ... [et al.] -- Phase II trials with anticancer agents / Hui K. Gan, J. Jack Lee and Lillian L. Siu -- Phase III clinical trials with anticancer agents / Wendy R. Parulekar and Daniel J. Sargent -- Pharmacokinetic studies in early anticancer drug development / Alex Sparreboom and Sharyn D. Baker -- Pharmacodynamic studies in early phase drug development / D. Ross Camidge, Robert C. Doebele and Antonio Jimeno -- Prediction of antitumor response / Fred R. Hirsch and Yu Shyr -- Imaging studies in anticancer drug development / David A. Mankoff -- Role of the U.S. Food and drug administration in cancer drug development / Ann T. Farrell, Ramzi N. Dagher and Richard Pazdur -- Early clinical trials with cytotoxic agents / M.J.A. de Jonge and Jaap Verweij -- Challenges and successes in developing effective anti-angiogenic agents / Laura Q.M. Chow and S. Gail Eckhardt -- Targeted therapeutics in cancer treatment / Colin D. Weekes and Manuel Hidalgo -- Cancer chemoprevention / Christopher H. Lieu, William N. William Jr. and Scott Lippman -- Combined modality therapy in cancer management / David Raben and Kyle Rusthoven -- Cancer vaccines / Daniel Laheru -- Optimising the development of antibodies as treatment for cancer / Craig P. Carden, Hendrik-Tobias Arkenau and Johann S. de Bono -- Oligonucleotide therapeutics / Cy A. Stein, Britta Hoehn and John Rossi -- Anticancer drug development in pediatric patients / Lia Gore and Margaret Macy -- Clinical trials in special populations / S. Percy Ivy ... [et al.] -- NCI-sponsored clinical trials / Andriana Papaconstantinou and Janet E. Dancey.
  • Cancer biotherapy : general principles / Robert K. Oldham -- The pathogenesis of cancer metastasis : relevance to therapy / Sun-Jin Kim ... [et al.] -- Developmental therapeutics and the design of clinical trials / Robert K. Oldham -- Recombinant proteins and gnomics in cancer therapy / Kapil Mehta ... [et al.] -- Current concepts in immunology / Robert K. Oldham -- Therapeutic approaches to cancer-associated immune suppression / Robert K. Oldham -- Cancer vaccines / Kenneth A. Foon and Malek M. Safa -- Cytokines / Walter M. Lewko and Robert K. Oldham -- Interferons : therapy for cancer / David Goldstein ... [et al.] -- Monoclonal antibody therapy / Robert O. Dillman -- Immunotoxins / Arthur E. Frankel, Jung-Hee Woo, and David M. Neville -- Drug immunoconjugates / Malek Safa, Kenneth A. Foon, and Robert K. Oldham -- Targeted radionuclide therpy of cancer / John M. Pagel ... [et al.] -- Stem cell/bone marrow transplantation as biotherapy / Robert K. Oldham -- Cellular immunotherapy (CI), where have we been and where are we going? / John R.Yanelli -- Growth and differentiation factors as cancer therapeutics / Kapil Mehta, Robert K. Oldham, and Bulent Ozpolat -- Granulocyte colony-stimulating factor : biology and clinical potential / MaryAnn Foote and George Morstyn -- Granulocyte-macrophage colony-stimulating factor / MaryAnn Foote and George Morstyn -- Cancer gene therapy / Donald J. Buchsbaum ... [et al.] -- Regulatory process for approval of biologicals for cancer therapy / Antonio J. Grillo-López -- Cancer biotherapy : 2009 disease-related activity / Robert K. Oldham and Robert O. Dillman -- Biological therapy of melanoma / Robert K. Oldham -- Biological therapy of genitourinary cancer / Robert K. Oldham -- Biological therapy of colon cancer / Robert O. Dillman -- Biological therapy of breast cancer / Robert O. Dillman -- Biological therapy of lung cancer / Robert O. Dillman -- Biological therapy of B and T cell lymphoproliferative disorders / Robert O. Dillman -- Biological therapy of multiple myeloma / Robert K. Oldham -- Biological therapy of squamous cell cancers of the head and neck / Robert O. Dillman -- Biological therapy of glioblastoma / Robert O. Dillman -- Speculations for 2009 and beyond / Robert K. Oldham.
  • Plastic surgery: a component in the comprehensive care of cancer patients -- The principles of cancer reconstruction -- Breast reconstruction: timing and coordination with adjuvant therapy -- Breast reconstruction: autogenous tissue -- Breast reconstruction: implant and nipple reconstruction -- Skin cancer and reconstruction -- Lip, cheek, and scalp reconstruction -- Reconstruction of mandible, maxilla, and skull base -- Pharynx, cervical esophagus, and oral cavity reconstruction -- Concepts in nasal reconstruction -- Extremity reconstruction -- Abdominal wall tumors and their reconstruction -- Reconstruction of the intra-abdominal pelvis and the perineum -- Management of chemotherapeutic agent extravasation and radiation therapy adverse effects.
  • Basic Principles of Cancer Genetics / Leif W. Ellisen and Daniel A. Haber -- Principles of Cancer Genetic Counseling and Genetic Testing / Kristen M. Shannon and Devanshi Patel -- Genetics of Hereditary Breast Cancer / Paula D. Ryan -- Surgical Management of Hereditary Breast and Ovarian Cancer / Michelle C. Specht, Marcela G. del Carmen and Barbara L. Smith -- Hereditary Colon Cancer: Colonic Polyposis Syndromes / Andrew T. Chan and Daniel C. Chung -- Hereditary Colon Cancer: Lynch Syndrome / Eunice L. Kwak and Daniel C. Chung -- Hereditary Pancreatic Cancer / Janivette Alsina and Sarah P. Thayer -- Hereditary Diffuse Gastric Cancer / Prakash K. Pandalai and Sam S. Yoon -- Familial Renal Cell Cancers and Pheochromocytomas / Gayun Chan-Smutko and Othon Iliopoulos -- Familial Atypical Mole Melanoma (FAMM) Syndrome / Elizabeth D. Chao, Michele J. Gabree and Hensin Tsao -- Multiple Endocrine Neoplasia / Yariv J. Houvras and Gilbert H. Daniels -- Pediatric Malignancies: Retinoblastoma and Wilms' Tumor / David A. Sweetser and Eric F. Grabowski -- Neurofibromatosis and Schwannomatosis / Miriam J. Smith and Scott R. Plotkin -- The HapMap Project and Low-Penetrance Cancer Susceptibility Alleles / Edwin Choy and David Altshuler -- Somatic Genetic Alterations and Implications for Targeted Therapies in Cancer (GIST, CML, Lung Cancer) / Alice T. Shaw, Eyal C. Attar, Edwin Choy and Jeffrey Engelman.
  • Section I. Introduction of cancer biology and cancer genetics -- Section II. Molecular techniques -- Section III. Molecular tests and cancer management -- Section IV. Molecular diagnostics of common malignancies -- Section V. Molecular basis of cancer therapeutics -- Section VI. Personalized medicine and targeted therapy of cancer -- Section VII. Future of molecular diagnostics and personalized cancer medicine.
  • Selecting the right targets for cancer therapy / Miguel H. Bronchud -- Clinical importance of prognostic factors: moving from scientifically interesting to clinically useful / N. Lynn Henry and Daniel F. Hayes -- Genetic markers in sporadic tumors / Elena Tamborini ... [et al.] -- Genetic markers in breast tumors with hereditary predisposition / Tatyana A. Grushko and Olufunmilayo I. Olopade -- Circulating tumor markers / Alan Horwich and Gill Ross -- Antibody-based proteomics analysis of tumor cell signaling pathways / Steven Pelech and Hong Zhang -- Gene expression arrays for pathway analysis in cancer research / Xiang Sean Yu ... [et al.] -- Signaling pathways in cancer / Daniel Kalderon -- Estrogen receptor pathways and breast cancer / Jing Peng and V. Craig Jordan -- Cyclin-dependent kinases and their regulators as potential targets for anticancer therapeutics / Marcos Malumbres -- Angiogenesis switch pathways / Jaume Piulats and Francesc Mitjans -- Apoptosis pathways and new anticancer agents / Frank A.E. Kruyt, Jose A. Rodriguez, and Giuseppe Giaccone -- Genomic instability, DNA repair pathways and cancer / Gabriel Capellá, Josep Balart, and Miquel Angel Peinado -- Epigenomics and cancer / Isabel Lopéz de Silanes and Manel Esteller -- Harnessing the power of immunity to battle cancer: Much ado about nothing or All's well that ends well? / Angelo A. Cardoso -- Aurora Kinases: a new target for anticancer drug development / Teresa Macarulla, Francisco Javier Ramos, and Josep Tabernero -- Emerging molecular therapies: drugs interfering with signal transduction pathways / Alison H.M. Reid, Richard Baird, and Paul Workman -- Suicide gene therapy / Silke Schepelmann, Ion Niculescu-Duvaz, and Caroline J. Springer -- Genotypes that predict toxicity and genotypes that predict efficacy of anticancer drugs / Rosario García-Campelo ... [et al.] -- A personal account of the chemoprevention of breast cancer: possible or not possible? / V. Craig Jordan.
  • Cell death : history and future / Zahra Zakeri and Richard A. Lockshin -- Caspase mechanisms / Guy S. Salvesen and Stefan J. Riedl -- The mitochondrial death pathway / Anas Chalah and Roya Khosravi-Far -- Apoptotic pathways in tumor progression and therapy / Armelle Melet ... [et al.] -- Therapeutic targeting of death pathways in cancer : mechanisms for activating cell death in cancer cells / Ting-Ting Tan and Eileen White -- Overcoming resistance to apoptosis in cnacer therapy / Peter Hersey, Xu Dong Zhang, and Nizar Mhaidat -- Trail receptors : targets for cancer therapy / Robin C. Humphreys and Wendy Halpern -- Rational design of therapeutics targeting the BCL-2 family : are some cancer cells primed for death but waiting for a final push? / Victoria Del Gaizo Moore and Anthony Letai -- Autophagy and tumor suppression : recent advancesin understanding the link between autophagic cell death pathways and tumor development / Shani Bialik and Adi Kimchi -- Regulation of programmed cell death by the P53 pathway / Kageaki Kuribayashi and Wafik S. El-Deiry -- Regulation of programmed cell death by NF-[kappa]B and its role in tumorigenesis and therapy / Yongjun Fan ... [et al.] -- Targeting proteasomes as therapy in multiple myeloma / Dharminer Chauhan, Teru Hideshima, and Kenneth C. Anderson -- Histone deacetylase inhibitors : mechanisms and clinical significance in cancer : HDAC inhibitor-induced apoptosis / Sharmila Shankar and Rakesh K. Srivastava -- RNA interference and cancer : endogenous pathways and therapeutic approaches / Derek M. Dykxhoorn, Dipanjan Chowdhury, and Judy Lieberman -- Cancer stem cells and impaired apoptosis / Zainab Jagani and Roya Khosravi-Far.
  • Prominin-1 (CD133) 2013, Springer
  • Virology and pathogenesis / Pfister, H. -- Epidemiology of mucosotropic papillomaviruses / Gissmann, L. -- Condylomata acuminata / Gross, G. -- Recurrent respiratory papillomatosis / Wittekindt, C.; Wagner, S.; Klussmann, J.P. -- Cervical cancer and intraepithelial neoplasia / Schneider, A. ... [et al.] -- Cancer and intraepithelial neoplasia of the vulva and vagina / Petry, K.U. -- Penile cancer and penile intraepithelial neoplasia / Gross, G. -- Anal cancer and intraepithelial neoplasia / Wieland, U. ; Kreuter, A. -- Tonsillar cancer / Klussmann, J.P.; Wagner, S.; Wittekindt, C. -- Cytology / Ikenberg, H. -- Concepts of biomarker development / von Knebel Doeberitz, M.; Vinokurova, S.; Reuschenbach, M. -- Detection of human papillomavirus DNA and RNA / Ikenberg, H. -- Human papillomavirus testing in primary screening for cervical cancer / Petry, K.U. -- Primary prevention by vaccination / Kaufmann, A.M.; Gissmann, L.
  • Mechanistic aspects of COX-2 expression in colorectal neoplasia -- Mode of action of aspirin as a chemopreventive agent -- Coxibs: pharmacology, toxicity and efficacy in cancer clinical trials -- COX-2 active agents in the chemoprevention of colorectal cancer -- New NSAID targets and derivatives for colorectal cancer chemoprevention -- Aspirin in prevention of sporadic colorectal cancer: current clinical evidence and overall balance of risks and benefits -- Nutritional agents with anti-inflammatory properties in chemoprevention of colorectal neoplasia -- Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC).
  • Prostate biopsy 2008, Springer
    Defining the problem : from subclinical disease to clinically insignificant prostate cancer / Wael Sakr -- What every patient should know about prostate cancer before he submits to biopsy of his prostate / Thomas A. Stamey, Rosalie Nolley, and Dorothea Torti -- Prostate-specific antigen and prostate cancer screening / Stacy Loeb, Misop Han, and William J. Catalona -- The role of complexed prostate-specific antigen in prostate cancer screening / Matthew E. Nielsen and Alan W. Partin -- Newly recognized forms of prostate-specific antigen and emerging molecular markers / Eduardo I. Canto and Kevin M. Slawin -- The role of prostate-specific antigen velocity in the diagnosis and management of prostate cancer / H. Ballentine Carter -- Prostate cancer screening : navigating the controversy / Timothy C. Brand and Ian M. Thompson -- Prostate cancer nomograms and how they measure up to neural networks / Pierre I. Karakiewicz and Michael W. Kattan -- Preparation for prostate biopsy / Alan M. Nieder and Mark S. Soloway -- Principles of prostate ultrasound / Martha K. Terris -- Minimizing pain and optimizing patient experience during prostate biopsy / J. Stephen Jones -- Prostate biopsy techniques / Katsuto Shinohara -- Biopsy strategies-how many and where? / Joseph C. Presti, Jr. -- Transperineal prostate biopsy / Paolo Emiliozzi and Vito Pansadoro -- Repeat prostate biopsies and the Vienna nomograms / Bob Djavan and Sibylle Marihart -- Saturation biopsy for detection and characterization of prostate cancer / J. Stephen Jones -- Pathologic implications of prostate biopsy / Ming Zhou and Cristina Magi-Galluzzi -- Complications of transrectal ultrasound-guided prostate biopsy / Sam S. Chang and Michael S. Cookson -- Management and controversies of high-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation on prostate biopsy / Alon Z. Weizer ... [et al.] -- Future directions in prostate cancer diagnosis / Nicholas J. Fitzsimons ... [et al.]
  • Anatomy and Normal Histology of the Prostate Pertinent to Biopsy Practice -- Prostate Needle Biopsy Sampling Techniques: Impact on Pathological Diagnosis -- Diagnosis of Limited Cancer in Prostate Biopsy -- Immunohistochemistry in Prostate Biopsy Evaluation -- Contemporary Approach to Gleason Grading of Prostate Cancer -- Histologic Variants of Prostate Carcinoma -- Benign Mimics of Prostate Carcinoma -- Atypical Cribriform Lesions of the Prostate Gland: Emerging Concepts of Intraductal Carcinoma of the Prostate (IDC-P) -- High-Grade Prostatic Intraepithelial Neoplasia -- Atypical Glands Suspicious for Cancer -- Spindle Cell Lesions of the Prostate Gland -- Treatment Effect in Benign and Malignant Prostate Tissue -- Molecular Biology of Prostate Cancer and Emerging Diagnostic and Prognostic Biomarkers -- Biopsy Specimen Handling, Processing, Quality Assurance Program -- Reporting of Prostate Biopsy.
  • Prostate cancer 2013, Springer
  • Prostate cancer 2007, Springer
  • Prostate cancer 2013, Springer
  • Prostate cancer 2008, Springer
    Histopathology and molecular biology of prostate atrophy: a lesion associated with inflammation, prostate intraepithelial neoplasia, and prostate cancer -- Epigenetic gene silencing in prostate cancer -- Inherited genetic changes in prostate cancer -- Prostate molecular oncogenesis: gene deletions and somatic mutations -- Somatic genetic changes in prostate cancer: androgen receptor alterations -- Androgen receptor in prostate cancer progression -- Epigenetic modification and aceylation of androgen receptor regulate prostate cellular growth -- Estrogen receptor a [alpha] and b [beta] in the regulation of normal and malignant prostate epithelium -- Estrogen action in normal prostate epithelium and in prostate cancer -- Hypoxia-inducible factor 1 in the angiogenesis of prostate cancer -- Signal transduction by the Ras-MAP kinase pathway in prostate cancer progression -- Transcription factors STAT5 and STAT3: survival factors for prostate cancer cells -- Role of P13K-Akt and PTEN in the growth and progression of prostate cancer -- New perspectives in prediction of clinical outcome of prostate cancer; TMPRSS2-ETS gene fusion in prostate cancer -- New directions in radiation therapy of prostate cancer: brachytherapy and intensity-modulated radiation therapy -- The current knowledge of hormonal therapy in the treatment of prostate cancer -- Advances in surgical intervention of porstate cancer: comparison of the benefits and pitfalls of retropubic, perineal, and laparoscopic radical prostatectormy -- Targeted therapy trials for prostate cancer -- New perspectives on chemotherapy in prostate cancer -- Concluding remarks: the future of prostate cancer.
  • Prostate cancer. 2nd ed. 2007, Springer
    Xenograft models of human prostate cancer -- The pathology of human prostatic atrophy and inflammation -- Tissue microarrays in prostate cancer research -- Prostate (cancer) stem cells -- Cancer-host interactions: a paradigm shift brings new understanding and new opportunities -- Androgen receptor function in prostate cancer progression -- Hedgehog signaling in development and cancer -- Cholesterol, cell signaling, and prostate cancer -- Gene therapy for advanced prostate cancer -- Role of transforming growth factor-ss in immunotherapy of prostate cancer -- Biology and therapeutic basis of prostate cancer bone metastasis -- Molecular imaging: noninvasive strategies to visualize gene expression in living subjects -- Quantum dot nanotechnology for prostate cancer research -- Expression profiling of prostate cancer progression -- Somatic alterations in prostate cancer progression -- Linkage studies of prostate cancer families to identify susceptibility genes -- Somatic DNA methylation changes and prostatic carcinogenesis -- Telomeres, telomerase, chromosome stability, and prostate cancer -- Racial differences in prostate cancer mortality -- Radiotherapy for the treatment of locally advanced prostate cancer -- Recombinant antibody candidates for treatment of prostate cancer -- Differentiation agents and epigenomic therapies: an overview and potential use for prostate cancer -- Taxane-based chemotherapy for prostate cancer -- Co-targeting therapeutics for hormone refractory prostate cancer -- Intercellular targets of prostate cancer -- Novel and efficient translational clinical trial designs in advanced prostate cancer.
  • Proteases and cancer 2009, Springer Protocols
    1. Delineating protease functions during cancer development / Nesrine I. Affara, Pauline Andreu, and Lisa M. Coussens -- 2. Proteolytic systems: constructing degradomes / Gonzalo R. Ordóñez ... [et al.] -- 3. Microarrays for protease detection in tissues and cells / Kamiar Moin ... [et al.] -- 4. Positional scanning synthetic combinatorial libraries for substrate profiling / Eric L. Schneider and Charles S. Craik -- 5. Mixture-based peptide libraries for identifying protease cleavage motifs / Benjamin E. Turk -- 6. High throughput substrate phage display for protease profiling / Boris Ratnikov, Piotr Cieplak, and Jeffrey W. Smith -- 7. Imaging specific cell surface protease activity in living cells using reengineered bacterial cytotoxins / John P. Hobson ... [et al.] -- 8. Cell-based identification of natural substrates and cleavage-sites for extracellular proteases by SILAC proteomics / Magda Gioia, Leonard J. Foster, and Christopher M. Overall -- 9. Optical proteolytic beacons for in vivo detection of matrix metalloproteinase activity -- J. Oliver McIntyre and Lynn M. Matrisian -- 10. Dissecting the urokinase activation pathway using urokinase-activated anthrax toxin / Shihui Liu ... [et al.] -- 11. On-demand cleavable linkers for radioimmunotherapy / Pappanaicken R. Kumaresan, Juntao Luo, and Kit S. Lam.
  • Protein kinase C in cancer signaling and therapy: introduction and historical perspective -- Regulation of conventional and novel protein kinase C isozymes by phosphorylation and lipids -- Phorbol esters and diacylglycerol: the PKC activators -- Diacylglycerol signaling: the C1 domain, generation of DAG and termination of signals -- Regulation of PKC by protein-protein interaction in cancer -- Introduction: PKC isozymes in the control of cell function -- Regulation and function of protein kinase C signaling -- PKC and control of the cell cycle -- PKC and the control of apoptosis -- Atypical PKC's, NF-kB and inflammation -- Introduction: PKC and cancer -- Protein kinase C, p53, and DNA damage -- PKCs as mediators of the hedgehog and Wnt signaling pathways -- PKC-PKD interplay in cancer -- Transgenic mouse models to investigate functional specificity of protein kinase C isoforms in the development of squamous cell carcinoma, a nonmelanoma human skin cancer -- PKC isozymes and skin cancer -- PKC and breast cancer -- PKC and prostate cancer -- Protein kinase C and lung cancer -- Introduction [PKC isozymes as targets for cancer therapy] -- PKC and resistance to chemotherapeutic agents -- PKCd as a target for chemotherapeutic drugs -- Atypical PKCs as targets for cancer therapy.
  • Protein tyrosine kinases 2006, Springer
    Protein tyrosine kinases as targets for cancer and other indications / Mark Pearson, Carlos Garcia-Echeverria, Doriano Fabbro -- Inhibitors of signaling interfaces: targeting Src homology 2 domains in drug discovery / Carlos Garcia-Echeverria -- PI 3-kinase inhibition: a target for therapeutic intervention / Peter M. Finan, Stephen G. Ward -- Src as a target for pharmaceutical intervention: potential and limitations / Mira Susa ... [et al.] -- Activated FLT3 receptor tyrosine kinase as a therapeutic target in leukemia / Blanca Scheijen, James D. Griffin -- JAK kinases in leukemias/lymphomas and multiple myeloma / Renate Burger, Martin Gramatzki -- Glivec (Gleevec, Imatinib, STI571): a targeted therapy for CML / Elisabeth Buchdunger, Renaud Capedeville -- Platelet-derived growth factor: normal function, role in disease, and applications of PDGF antagonists / Tobias Sjoblom ... [et al.] -- Structural biology of protein tyrosine kinases / Sandra W. Cowan-Jacob ... [et al.] -- Testing of signal transduction inhibitors in animal models of cancer / Terence O'Reilly, Robert Cozens -- Phosphoproteomics in drug discovery and development / Michel F. Moran.
  • Proton beam therapy 2013, Springer
    While radiation therapy is a mainstay of cancer treatment, traditional linear accelerators mainly use photons to irradiate cancerous tissue. Photons deposit much more energy in the surrounding normal tissue than protons. Proton beam therapy is a revolutionary alternative that deposits most of its cancer-killing energy within the area of the tumor, thereby potentially improving cure rates and reducing side effects in properly selected patients. This book guides the reader through existing evidence supporting proton beam therapy for an increasing number of patients and conditions, including pediatric, prostate, and lung cancer, mediastinal tumors, skull base tumors, conditions of the eye, and sarcomas.
  • Psycho-oncology 2014, Springer
    Psycho-oncology is a thriving discipline in cancer care, and numerous research activities have been undertaken in the endeavor to improve treatment outcomes and to gain a better understanding of the psychological consequences of cancer. This book presents and discusses the latest findings from science and practice for a broad range of psychological and social issues related to cancer and its treatments. Not only are general psychosocial impacts of cancer described, but the very common fear of progression is elucidated. The relevance of psychooncology at different stages of disease (during oncological treatment, in rehabilitation, and during palliative care) is explained, and various psychooncological interventions are illustrated. Other important topics are the experience of being a cancer survivor, who may be cured but not be healthy, the psychological burden on relatives, and gender differences in coping with cancer. Quality of life and patient-reported outcomes are also commented on since they are among the key benchmarks for successful coping with the diagnosis of cancer, its treatment, and its late effects.
  • Psychoneuroimmunology and cancer : incidence, progression, and quality of life -- Inflammation, chronic disease, and cancer : is psychological distress the common thread? -- Psychological aspects of hereditary cancer risk counseling and genetic testing -- Mastectomy to prevent breast cancer : psychosocial aspects of women's decision-making -- Decision aids in advanced cancer -- Cancer fatalism : attitudes toward screening and care -- Positive psychology perspectives across the cancer continuum : meaning, spirituality, and growth -- Stress, coping, and hope -- Religiousness and spirituality in coping with cancer -- Controversies in psycho-oncology -- Psychosocial interventions for couples coping with cancer : a systematic review -- The impact of cancer and its therapies on body image and sexuality -- Cancer caregivership -- Psychosocial interventions in cancer -- Quality of life -- Exercise for cancer patients : treatment of side effects and quality of life -- Use of the classic hallucinogen Psilocybin for treatment of existential distress associated with cancer -- The placebo and nocebo effects in cancer treatment -- Psychological factors and survivorship : a focus on post-treatment cancer survivors -- Complementary mind-body therapies in cancer -- End-of-life communication in cancer care -- The intersection between cancer and caregiver survivorship -- Resources for cancer patients -- Bringing it all together.
  • Quantitative MRI in cancer 2012, CRCnetBASE
  • Radiation oncology 2008, Springer
  • Radiation oncology 2012, Springer
    Radiation Physics --Radiobiology --Clinical Radiation Oncology --Central Nervous System Tumors --Head and Neck Cancers --Lung Cancer --Breast Cancer --Genitourinary System Cancers --Gynecological Cancers --Gastrointestinal System Cancers --Soft Tissue Sarcoma --Skin Cancer --Lymphomas and Total Body Irradiation --Pediatric Tumors --Rare Tumors and Benign Diseases.
  • Central Nervous System Tumors: Adult and Pediatric -- Skin Cancer -- Head and Neck Cancer -- Lung Cancer -- Tumors of the Mediastinum -- Breast Cancer -- Upper Gastrointestinal Cancers -- Lower Gastrointestinal Cancers -- Urinary System Cancers -- Male Genitourinary Cancer -- Gynecologic Malignancies -- Hematologic Malignancies -- Sarcoma -- Pediatric Non-central Nervous System Cancers -- Benign and Metastatic Disease.
  • Ideal for on-the-spot consultation, this pocket manual, Radiation Oncology: Management Decisions, provides easily accessible information for residents and practitioners in radiation oncology. It presents the most essential information that is immediately required in the clinical setting. The first eight chapters of the book focus on key basic concepts; the remaining 46 chapters describe treatment regimens for all cancer sites and tumor types. Includes coverage of pain and palliation, and covers all latest therapeutic techniques. This edition includes expanded information on image-guided therapy, 3D techniques, and 4D protocols. The updated cancer staging guidelines have been used throughout the manual. In addition, there is a brand-new chapter devoted to QUANTEC dosage recommendations.
  • Radiation toxicity 2006, Springer
  • Radioguided surgery 2008, Springer
    Part I. Chemistry and Physics -- Radiopharmaceuticals for Radioguided Surgery / Esteban Obenaus, Paola A. Erba, Marco Chinol, Christophe Van de Wiele and Gyozo A. Janoki, et al. -- Physical Performance Parameters of Intraoperative Probes / Carlo Chiesa, Francesca Toscano, Mario Mariani and Emilio Bombardieri -- Positron-Sensitive Probes / Schlomo Schneebaum, Richard Essner and Einat Even-Sapir -- Gamma Ray Imaging Probes for Radioguided Surgery and Site-Directed Biopsy / Francesco Scopinaro and Alessandro Soluri -- Radiation Protection in Radioguided Surgery / Edwin C. Glass and Wendy A. Waddington -- Training and Credentialing for Radioguided Surgery / Eric D. Whitman -- Part II. Sentinel Lymph Nodes -- The Anatomy and Physiology of Lymphatic Circulation / Preya Ananthakrishnan, Giuliano Mariani, Luciano Moresco and Armando E. Giuliano -- The Role of Lymph Node Staging for Clinical Decision Making in Patients with Solid Cancers / Fausto Badellino, Ilaria Pastina, Elisa Borsò, Sergio Ricci and H. William Strauss, et al. -- Sentinel Lymph Node Biopsy in Patients with Breast Cancer / Charles E. Cox, John M. Cox, Giuliano Mariani, Caren E.G. Wilkie and Laura B. White, et al. -- Sentinel Lymph Node Biopsy in Cutaneous Melanoma / Jeffrey E. Gershenwald, Roger F. Uren, Giuliano Mariani and John F. Thompson -- Dynamic Sentinel Lymph Node Biopsy in Penile Carcinoma / Simon Horenblas, Bin K. Kroon, Renato A. Valdés Olmos and Omgo E. Nieweg -- Sentinel Lymph Node Biopsy in Cancer of the Head and Neck / Luca Calabrese, David Soutar, Jochen Werner, Roberto Bruschini and Concetta De Cicco, et al. -- Sentinel Lymph Node Biopsy in Gynecologic Malignancies / Emilio Bombardieri, Marco Maccauro, Rosanna Fontanelli, Francesco Raspagliesi and Giovanni Paganelli -- Sentinel Lymph Node Biopsy in Cancers of the Gastrointestinal Tract / Yuko Kitagawa, Sukamal Saha and Masaki Kitajima --Sentinel Lymph Node Biopsy in Prostatic Cancer / Alexander Winter, Harry Vogt, Dorothea Weckermann, Rolf Harzmann and Friedhelm Wawroschek -- Radioguided Biopsy of the Sentinel Lymph Node in Patients with Non-Small Cell Lung Cancer / Giuseppe Boni, Gianpiero Manca, Franca M. A. Melfi, Marco Lucchi and Alfredo Mussi, et al. -- Sentinel Lymph Node Biopsy in Thyroid Cancer / Massimo Salvatori, Domenico Rubello, Michael J. O'Doherty, Maria Rosa Pelizzo and Giuliano Mariani -- Histopathology of Sentinel Lymph Nodes / Giuseppe Viale, Giovanni Mazzarol and Eugenio Maiorano -- Frozen Section and Imprint Cytology in Sentinel Lymph Node Biopsy for Breast Cancer / Santo V. Nicosia and Charles E. Cox -- Molecular Assessment of Sentinel Lymph Nodes / Farin Amersi, Armando E. Giuliano and Dave S.B. Hoon -- Part III. Occult Lesion Localization -- Where It All Began: The Heritage of Radioimmunoguided Surgery / Fausto Badellino, Mario Roselli, Marzio Perri, Fiorella Guadagni and Giuliano Mariani -- Radioguided Occult Lesion Localization in the Breast / Giovanni Paganelli, Concetta De Cicco, Giovanna Gatti and Alberto Luini -- Minimally Invasive Radioguided Parathyroidectomy in Primary Hyperparathyroidism / James Norman, Domenico Rubello, Armando E. Giuliano and Giuliano Mariani -- Radioguided Surgery of Neuroendocrine Tumors / Richard P. Baum, Sergio Sandrucci and Stefan Adams -- Radioguided Surgery of Solitary Pulmonary Nodules / Giuseppe Boni, Franca M. A. Melfi, Gianpiero Manca, Marco Lucchi and Alfredo Mussi, et al. -- Radioguided Surgery of Occult Lesions in Patients with Thyroid Cancer / Domenico Rubello, Massimo Salvatori, Maria Rosa Pelizzo, Giuseppe Boni and Giuliano Mariani -- Radioguided Bone Lesion Localization / Gianpiero Manca, Giuliano Mariani and Lary A. Robinson.
  • Radiopharmaceuticals 2011, CRCnetBASE
    "This comprehensive overview details the process of radiopharmaceutical development, from cellular studies to animal experiments to the design and implementation of clinical trials. It examines the relative benefits of various radiopharmaceuticals and provides guidance on dose estimation and agent selection. Utilizing figures of merit for quantitative assessment, it covers standard medical internal radiation dose (MIRD), absorbed dose method for imaging agents, vivo methods for obtaining activity data, errors of activity estimation techniques, phantom-based and patient-based dose estimates and their associated uncertainties, and options available to clinical physicists. Supported by numerous examples from clinical trials, it discusses two and three dimensional estimation processes, including modern hybrid scanners such as SPECT/CT and PET/CT"--Provided by publisher.
  • In cancer research, a traditional phase II trial is designed as a single-arm trial that compares the experimental therapy to a historical control. This simple trial design has led to several adverse issues, including increased false positivity of phase II trial results and negative phase III trials. To rectify these problems, oncologists and biostatisticians have begun to use a randomized phase II trial that compares an experimental therapy with a prospective control therapy.
  • Epidemiology and databases -- Rare and uncommon gynecological cancers: a clinical guide -- The contribution of diagnostic imaging in rare gynecological malignancies -- Mucinous cancers: ovary -- Pseudomyxoma peritonei -- Ovarian clear cell carcinoma -- Clear cell carcinoma of the ovary -- The continuum of serious ovarian tumors of low malignant potential and low-grade serous carcinoma of the ovary -- Sex cord-stromal tumors -- Squamous cell carcinomas arising from dermoids -- Ovarian carcinosarcomas -- Small cell and neuroendocrine cancers of the ovary -- Primary ovarian carcinoids and neuro-endocrine tumors including struma ovarii -- Reed uterine carcinosarcomas -- Leiomyosarcomas of uterus -- Mucinous tumors of the uterine corpus -- Clear cell cancers of uterus -- Small cell and neuroendocrine cancers of the cervix -- Primary malignant melanoma of the vulva and vagina -- Gynecologic cancers in pregnancy: guidelines of an international consensus meeting.
  • Razoxane and dexrazoxane 2010, Springer
  • Re-irradiation 2011, Springer
  • Cancer continues to be one of the major causes of death throughout the developed world, which has led to increased research on effective treatments. Because of this, in the past decade, rapid progress in the field of cancer treatment has been seen. Recent Advances in Cancer Research and Therapy reviews in specific details some of the most effective and promising treatments developed in research centers worldwide. While referencing advances in traditional therapies and treatments such as chemotherapy, this book also highlights advances in biotherapy including research using Interferon and Super.
  • Rectal cancer 2013, Springer
  • Rectal cancer 2005, Springer
  • Rectal cancer 2010, Springer
  • Rectal cancer treatment 2005, Springer
  • Regional cancer therapy 2007, Springer
  • Renal cancer 2013, Springer
  • Renal cell cancer 2008, Springer
  • Renal cell carcinoma 2012, Springer
    Pt. 1. Biology of renal cell carcinoma -- pt. 2. Current and future molecular targets for RCC.
  • Renal cell carcinoma 2013, Springer
  • Targeted therapy for metastatic renal call carcinoma: overview -- Molecular genetics in inherited renal cell carcinoma: identification of targets in the hereditary syndromes -- Molecular targets in renal tumors: pathologic assessment -- Interferons and interleukin-2: molecular basis of activity and therapeutic results -- The molecular biology of kidney cancer and its clinical translation into treatment strategies -- VEGF: biologic aspects and clinical approaches -- VEGF and PDGF receptors: biologic relevance and clinical approaches to inhibition -- Sunitinib and axitinib in renal cell carcinoma -- Sorafenib in renal cell carcinoma -- Additional tyrosine kinase inhibitors in renal cell carcinoma -- Integrin [alpha]5[beta]1 as a novel therapeutic target in renal cancer -- Carbonic anhydrase IX: biology and clinical approaches -- Monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinoma: biological and clinical studies -- Chemokines in renal cell carcinoma: implications for tumor angiogenesis and metastasis -- P13K/Akt/mTOR pathway: a growth and proliferation pathway -- EGFR and HER2: relevance in renal cell carcinoma -- Proteasome-NF[kappa]B signaling pathway: relevance in RCC -- The role of hepatocyte growth factor pathway signaling in renal cell carcinoma -- Smac/DIABLO: a proapoptotic molecular target in renal cell cancer -- EphA2: a novel target in renal cell carcinoma -- Restoring host antitumoral immunity: how coregulatory molecules are changing the approach to the management of renal cell carcinoma -- The role of gangliosides in renal cell carcinoma -- Tumour necrosis factor: misnomer and therapeutic target -- Molecular markers for predicting prognosis of renal cell carcinoma -- Adjuvant therapy for renal cell carcinoma: targeted approaches.
  • Principles of cancer treatment: impact on reproduction -- Fertility preservation options for females -- Options for fertility preservation in men and boys with cancer -- Contraception and cancer treatment in young persons -- Sexual health during cancer treatment -- Unique reproductive concerns of young women with breast cancer -- Pregnancy and cancer -- Preimplantation genetic diagnosis for hereditary cancers -- Non-traditional family building planning -- Parenting with cancer I: developmental perspective, communication, and coping -- Parenting with cancer II: parenting at different stages of illness -- Pediatric oncology and reproductive health -- Institutional approaches to implementing fertility preservation for cancer patients -- Patient provider communication and reproductive health -- Fertility preservation in cancer patients: ethical considerations -- Legal issue and of assisted reproductive technologies.
  • Retinoblastoma 2010, Springer
  • Rho GTPases in cancer 2010, Springer
  • RNA and cancer 2013, Springer
    Coupling Between Transcription and Alternative Splicing /Ignacio E. Schor, Luciana I. Gómez Acuña, Alberto R. Kornblihtt --Detection of Alternatively Spliced or Processed RNAs in Cancer Using Oligonucleotide Microarray /Marieta Gencheva ... [et al.] --Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing /Lulzim Shkreta ... [et al.] --Alternative Splicing of Tumor Suppressors and Oncogenes /Claudia Ghigna, Silvano Riva, Giuseppe Biamonti --MicroRNAs in Cancer /Jianzhong Jeff Xi --The Perinucleolar Compartment: RNA Metabolism and Cancer /John T. Norton, Sui Huang --Regulation of ARE-mRNA Stability by Cellular Signaling: Implications for Human Cancer /Christian Kroun Damgaard, Jens Lykke-Andersen --Alternative Pre-mRNA Splicing, Cell Death, and Cancer /Kong Ruirui ... [et al.] --Oligonucleotide Therapeutics in Cancer /Jing Wan, John A. Bauman, Maria Anna Graziewicz, Peter Sazani --Clinical Perspective on Chemo-Resistance and the Role of RNA Processing /Nancy L. Krett, Shuo Ma, Steven T. Rosen.
  • Interdiction of sphingolipid metabolism to improve standard cancer therapies -- Diverse functions of ceramide in cancer cell death and proliferation -- Cermaide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance -- Use of acid sphingomyelinase for cancer therapy -- Hypoxia therapeuric resistance and sphingosine 1-phosphate -- Therapeutic potential of targeting SK1 in human cancers -- Sphinogosine kinase 1 in cancer -- Natural products as platforms for the design of sphingolipid-related anticancer agents.
  • Ch. 1. Anatomy and physiologic morphology -- Ch. 2. Abnormalities of mammary growth and development -- Ch. 3. Inflammatory and reactive tumors -- Ch. 4. Specific infections -- Ch. 5. Papilloma and related benign tumors -- Ch. 6. Myoepithelial neoplasms -- Ch. 7. Adenosis and microglandular adenosis -- Ch. 8. Fibroepithelial neoplasms -- Ch. 9. Ductal hyperplasia: ordinary and atypical -- Ch. 10. Precancerous breast disease: epidemiologic, pathologic, and clinical considerations -- Ch. 11. In Situ (intraepithelial) carcinoma: an overview -- Ch. 12. Staging of breast carcinoma -- Ch. 13. Intraductal carcinoma -- Ch. 14. Invasive duct carcinoma: assessment of prognosis, morphologic prognostic markers, and tumor growth rate -- Ch. 15. Tubular carcinoma -- Ch. 16. Papillary carcinoma -- Ch. 17. Medullary carcinoma -- Ch. 18. Carcinoma with metaplasia -- Ch. 19. Squamous carcinoma -- Ch. 20. Mucinous carcinoma -- Ch. 21. Apocrine carcinoma -- Ch. 22. Mammary carcinoma with endocrine features -- Ch. 23. Small cell (oat cell) carcinoma -- Ch. 24. Secretory carcinoma -- Ch. 25. Mammary carcinoma with osteoclast-like.giant cells -- Ch. 26. Cystic hypersecretory carcinoma and cystic hypersecretory hyperplasia -- Ch. 27. Adenoid cystic carcinoma -- Ch. 28. Cribriform carcinoma -- Ch. 29. Lipid-rich carcinoma -- Ch. 30. Gylcogen-rich carcinoma -- Ch. 31. Invasive micropapillary carcinoma -- Ch. 32. Paget's disease of the nipple -- Ch. 33. Lobular carcinoma In Situ and atypical lobular hyperplasia -- Ch. 34. Invasive lobular carcinoma -- Ch. 35. Unusual clinical presentations of carcinoma -- Ch. 36. Metastases in the breast from nonmammary malignant neoplasms -- Ch. 37. Benign proliferative lesions of the male breast -- Ch. 38. Carcinoma of the male breast -- Ch. 39. Breast tumors in children -- Ch. 40. Benign mesenchymal neoplasms -- Ch. 41. Sarcoma -- Ch. 42. Lymphoid and hematopoietic tumors -- Ch. 43. Pathologic effects of therapy -- Ch. 44. Cutaneous neoplasms -- Ch. 45. The pathology of axillary and intramammary lymph nodes -- Ch. 46. Pathologic examination of breast and lymph node specimens.
  • Anatomy and physiological morphology --Abnormalities of mammary growth and development --Inflammatory and reactive tumors --Specific infections --Papilloma and related benign tumors --Myoepithelial neoplasms --Adenosis and microglandular adenosis --Fibroepithelial neoplasms --Ductal hyperplasia: usual and atypical --Precancerous breast disease: epidemiological, pathological, and clinical considerations --Intraductal carcinoma --Invasive duct carcinoma: assessment of prognosis, morphologic prognostic markers, and tumor growth rate --Tubular carcinoma --Papillary carcinoma --Medullary carcinoma --Carcinoma with metaplasia --Squamous carcinoma --Mucinous carcinoma --Apocrine carcinoma --Mammary carcinomas with endocrine features --Small cell (oat cell) carcinoma --Secretory carcinoma --Mammary carcinoma with osteoclast-like giant cells --Cystic hypersecretory carcinoma and cystic hypersecretory hyperplasia --Adenoid cystic carcinoma --Cribriform carcinoma --Lipid-rich carcinoma --Glycogen-rich carcinoma --Invasive micropapillary carcinoma --Paget's disease of the nipple --Lobular carcinoma in situ and atypical lobular hyperplasia --Invasive lobular carcinoma --Unusual clinical presentations of carcinoma --Metastases in the breast from nonmammary malignant neoplasms --Benign proliferative lesions of the male breast --Carcinoma of the male breast --Breast tumors of children --Benign mesenchymal neoplasms --Sarcoma --Lymphoid and hematopoietic tumors --Pathologic effects of therapy --Cutaneous neoplasms --The pathology of axillary and intramammary lymph nodes --Pathologic examination of breast and lymph node specimens, including sentinel lympth nodes.
  • Selfish cell 2008, Springer
  • Serous effusions 2012, Springer
  • Sexual dysfunction presents a major challenge to physicians who take on the task of treating men with prostate cancer. While curing the disease and saving a life is paramount, improving technologies and therapies offer skilled surgeons and clinical oncologists the opportunity to eradicate the disease without compromising sexual function. In Sexual Function of the Prostate Cancer Patient, John Mulhall and a panel of internationally recognized experts on prostate cancer and sexual function assess in detail the current state of prostate cancer treatment. The authors offer a broad overview of the pathophysiology and treatment of erectile dysfunction in men with prostate cancer, reviewing the latest findings regarding erection-sparing radiation therapy and sexual function outcomes after laparascopic and robotic prostatectomy. Additional chapters discuss intra-operative maneuvers to minimize post-operative erectile dysfunction and pharmacologic penile preservation and rehabilitation. Timely and authoritative, Sexual Function in the Prostate Cancer Patient is a highly readable guide to preserving post-prostate cancer sexual function that no urologist or radiation and medical oncologist should be without.
  • Shaped-beam radiosurgery 2011, Springer
  • "The poor prognosis and high mortality for cancer patients are majorly ascribed to tumor metastasis, one of the most complicated pathological processes. Elucidation of molecular mechanisms for metastasis is essential for management and prevention of this lethal condition. In the book to be published, we take comprehensive review in regard with the signal mechanisms responsible for triggering a series of phenotypical changes of primary tumor which may lead to final colonization of the tumor in a second home. Specifically, the initial stage of tumor metastasis will be highlighted. The complex tumor microenvironment accumulate a lot of growth factors, inflammatory cytokines and extracellular matrix which may turn into a group of potent metastatic factors. An integrated and sustained signaling induced by these metastatic factors may trigger EMT, migration and invasion of primary tumor into surround tissue. Blockade of these signal pathways is the most effective approach for prevention of tumor metastasis. A lot of clinical trials are under way for this purpose and the outcome are promising. The expert reviews compiled in this book may encourage the researcher in this exciting field for future study."--Back cover
  • Signs in MR-mammography 2008, Springer
  • Skin Cancer 2014, Springer
  • Skin cancer 2011, Springer
  • Skin cancer management 2010, Springer
    Biopsy techniques and interpretation / Deborah F. MacFarlane and Ronald P. Rapini -- Topical therapies for nonmelanoma skin cancers / Abel Torres and Tejas Desai -- Chemical peels for precancerous skin lesions / Gary D. Monheit and Chad L. Prather -- Photodynamic therapy / Nathalie C. Zeitouni, Allan Oseroff, and David J. Najarian -- Intralesional and perilesional treatment of skin cancers / Christopher J. Arpey, Nicole M. Annest, Stephen B. Tucker, Ronald P. Rapini, and Deborah F. MacFarlane -- Electrodesiccation and curettage / Gloria F. Graham -- Cryosurgery / Gloria F. Graham -- Optimizing surgical outcomes / Thomas Stasko and Amy Ross -- Anesthesia / Susannah L. Collier and George J. Hruza -- Excision techniques, staples, and sutures / Mollie A. MacCormack -- Mohs surgery / Desiree Ratner and Jennifer L. MacGregor -- Cutaneous flaps / Tatyana Humphreys -- Techniques in skin grafting / Deborah F. MacFarlane -- Nail surgery and malignant tumors of the nail unit / Deborah F. MacFarlane and Richard K. Scher -- Practical management of melanoma / Mark F. Naylor -- Skin cancer in skin of color / Brooke A. Jackson -- Management of skin cancers in solid organ transplant recipients / John Carucci and Dariush Moussai -- Imaging of head and neck skin cancer / Komal Shah, Jane Onufer, and Deborah F. MacFarlane -- Radiation oncology in skin cancer treatment / Susan L. McGovern and Matthew T. Ballo -- When to refer out / Daniel M. Siegel, Laura T. Cepeda, and Deborah F. MacFarlane -- Chemoprevention of skin cancer / Fiona Zwald and David Lambert.
  • Protein kinase inhibitors -- Imatinib mesylate -- Erlotinib -- Axitinib -- Lapatinib -- Sorafenib -- Sunitinib -- Dasatinib -- Nilotinib -- Bosutinib -- Epigenetic modifiers -- Decitabine -- 5-Azacytidine/Azacitidine -- Cell cycle inhibitors -- Bortezomib -- Temsirolimus -- Danusertib (formerly PHA-739358): a novel combined pan-aurora kinases and third generation Bcr-Abl tyrosine kinase inhibitor -- BI_2536: targeting the mitotic kinase polo-like kinase 1 (Plk1) -- Other novel agents -- Imetelstat (GRN163L): Telomerase-based cancer therapy -- GDC-0449: targeting the hedgehog signaling pathway.
  • Sphingolipids in disease 2013, Springer
    Sphingolipids in Cancer.Sphingosine Kinase/Sphingosine 1-Phosphate Signaling in Cancer Therapeutics and Drug Resistance /Shanmugam Panneer Selvam, Besim Ogretmen --Using ASMase Knockout Mice to Model Human Diseases /Guoqiang Hua, Richard Kolesnick --New Perspectives on the Role of Sphingosine 1-Phosphate in Cancer /Susan Pyne, Nigel J. Pyne --Sphingolipids and Response to Chemotherapy /Marie-Thérèse Dimanche-Boitrel, Amélie Rebillard --Lung Cancer and Lung Injury: The Dual Role of Ceramide /Tzipora Goldkorn, Samuel Chung, Simone Filosto --Sphingolipids' Role in Radiotherapy for Prostate Cancer /Carla Hajj, Adriana Haimovitz-Friedman --Sphingolipids in Cardio-Reno-vascular Diseases.Sphingolipid Metabolism and Atherosclerosis /Xian-Cheng Jiang, Jing Liu --Cardiovascular Effects of Sphingosine-1-Phosphate (S1P) /Bodo Levkau --Cross Talk Between Ceramide and Redox Signaling: Implications for Endothelial Dysfunction and Renal Disease /Pin-Lan Li, Yang Zhang --Sphingolipids in Inflammation, Infection and Lung Diseases.Sphingolipids in Lung Endothelial Biology and Regulation of Vascular Integrity /Taimur Abbasi, Joe G. N. Garcia --Sphingolipids in Acute Lung Injury /Stefan Uhlig, Yang Yang --The Involvement of Sphingolipids in Chronic Obstructive Pulmonary Diseases /Irina Petrache, Daniela N. Petrusca --Ceramide in Cystic Fibrosis /Heike Grassmé, Joachim Riethmüller, Erich Gulbins --Regulation of the Sphingosine Kinase/Sphingosine 1-Phosphate Pathway /K. Alexa Orr Gandy, Lina M. Obeid --Bacterial Infections and Ceramide /Heike Grassmé, Katrin Anne Becker --Viral Infections and Sphingolipids /Jürgen Schneider-Schaulies, Sibylle Schneider-Schaulies --Ceramide in Plasma Membrane Repair /Annette Draeger, Eduard B. Babiychuk --Sphingolipids and Inflammatory Diseases of the Skin /Burkhard Kleuser, Lukasz Japtok --Sphingolipids in Obesity, Type 2 Diabetes, and Metabolic Disease /S. B. Russo, J. S. Ross, L. A. Cowart --Sphingolipids in Neuro-psychiatry and Muscle Diseases.Neuronal Forms of Gaucher Disease /Einat B. Vitner, Anthony H. Futerman Sphingolipids in Neuroinflammation /Laura Davies, Klaus Fassbender, Silke Walter --Sphingolipids in Psychiatric Disorders and Pain Syndromes /C. Mühle, M. Reichel, E. Gulbins, J. Kornhuber --Role of Sphingosine 1-Phosphate in Skeletal Muscle Cell Biology /Paola Bruni, Chiara Donati.
  • Part 1. Bone marrow-derived stem cells -- Part 2. Embryonic stem cells -- Part 3. Cancer stem cells.
  • Introduction /Simon S. Lo, Bin S. Teh, Jiade J. Lu and Tracey E. Schefter --Historical Development of Stereotactic Ablative Radiotherapy /Timothy D. Solberg, Robert L. Siddon and Brian Kavanagh --CyberKnife System /Jun Yang, John P. Lamond, Jing Feng, Xiaodong Wu and Rachelle Lanciano, et al. --Novalis and Varian Systems /Isaac I. Rosen and Ramiro Pino --Helical TomoTherapy System /Whitney Warren, Walter H. Grant III and Bin S. Teh --Elekta System /Julian R. Perks, Megan E. Daly, David Schlesinger and Stanley H. Benedict --Treatment Planning for Stereotactic Body Radiation Therapy /Moyed Miften, Shiva K. Das, Indrin J. Chetty and David Westerly --Launching a Stereotactic Body Radiation Therapy Program /Michael Lamba --Radiobiology of Stereotactic Body Radiation Therapy/Stereotactic Ablative Radiotherapy /Michael D. Story, Chaitanya Nirodi and Clinton Park --Primary Lung Cancer /Joe Y. Chang, Shervin M. Shirvani, Billy W. Loo Jr., John P. Lamond and Ben J. Slotman, et al. --Primary Liver Cancer /Higinia R. Cárdenes and Foster Lasley --Prostate Cancer /Hiromichi Ishiyama, Alan Katz, Angel I. Blanco, Jose Hinojosa and Simon S. Lo, et al. --Renal Cell Carcinoma /Bin S. Teh, Hiromichi Ishiyama, Angel I. Blanco, Lee E. Ponsky and Simon S. Lo, et al. --Gynecologic Cancer /Charles A. Kunos, Jeffrey Fabien, Yuxia Zhang, James Brindle and Nina A. Mayr --Pancreatic Cancer /A. Yuriko Minn, Daniel T. Chang and Albert C. Koong --Benign and Malignant Primary Spinal Tumors /Brett Cox, Iris C. Gibbs and Yoshiya Yamada --Non-Skull Base Head and Neck Cancer /Farzan Siddiqui, David Raben, Sue S. Yom, Jiade J. Lu and Min Yao --Skull Base Head and Neck Cancer /Sue S. Yom, David Raben, Farzan Siddiqui, Jiade J. Lu and Min Yao --Lung Metastasis /Neha Amin, Tracey E. Schefter, Paul Okunieff, Brian Kavanagh and Michael T. Milano --Liver Metastasis /Michelle Stinauer, Rachelle Lanciano, Tracey E. Schefter, Brian Kavanagh and Julie A. Carlson, et al. --Adrenal Metastasis /Mirna Abboud, Simon S. Lo, Arnold C. Paulino, Daniel E. Lehane and Bin S. Teh --Histology-Specific Metastasis /Michael T. Milano and Joseph K. Salama --Bone Metastasis /Mirna Abboud, Arnold C. Paulino, B. S. Teh, Simon S. Lo and Rex Marco --Spinal Metastasis /Simon S. Lo, Andrew E. Sloan, Mitchell Machtay, Bin S. Teh and Arjun Sahgal, et al. --Reported Toxicities Associated with Stereotactic Body Radiation Therapy /Simon S. Lo, Arjun Sahgal, Charles A. Kunos, Bin S. Teh and Min Yao, et al. --Normal Tissue Constraints /Simon S. Lo, Arjun Sahgal, Lijun Ma, Ben J. Slotman and Zhibin Huang, et al. --Erratum: Primary Liver Cancer /Higinia R. Cárdenes and Foster Lasley --Erratum: Bone Metastasis /Mirna Abboud, Arnold C. Paulino, B. S. Teh, Simon S. Lo and Rex Marco.
  • Targeting oncogenic drivers / Zhao, Y.; Adjei, A.A. (Buffalo, N.Y.) -- Successes and limitations of targeted cancer therapy in breast cancer / Curigliano, G.; Criscitiello, C. (Milan) -- Successes and limitations of targeted cancer therapy in colon cancer / Khne, C.-H. (Oldenburg) -- Successes and limitations of targeted cancer therapy in gastrointestinal stromal tumors / Casali, P.G. (Milano) -- Successes and limitations of targeted cancer therapy in lung cancer / Suda, K. (Osaka-Sayama/Fukuoka); Mitsudomi, T. (Osaka-Sayama) -- Successes and limitations of targeted cancer therapy in melanoma / Romano, R.; Michielin, O. (Lausanne) -- / successes and limitations of targeted cancer therapy in ovarian cancer / Damia, G. (Milan); Sessa, C. (Bellinzona) -- Successes and limitations of targeted therapies in renal cell carcinoma / Pracht, M.; Berthold, D. (Lausanne).
  • Suicide gene therapy 2004, Springer Protocols
  • Supportive oncology 2011, ScienceDirect
  • History of cerebellopontine angle surgery -- Microsurgical anatomy of the cerebellopontine angle by the retrosigmoid approach -- Neuropathology of the cerebellopontine angle and its surroundings -- Approaches to the cerebellopontine angle -- Vestibular schwannomas -- Neurofibromatosis Type 2 and other bilateral cerebellopontine angle tumors -- Meningiomas -- Cerebellopontine angle epidermoids -- Nonvestibular schwannomas -- Jugular foramen tumors -- Other cerebellopontine angle tumors -- Management of facial palsy.
  • Surgery of spinal tumors 2007, Springer
    History -- Anatomy -- Intramedullary tumors -- Extramedullary tumors -- Epidural tumors.
  • Historical Background or De quibusdam Renum glandulis: The History of Adrenals /Donatella Lippi --Surgical Anatomy /Celestino Pio Lombardi, Carmela De Crea, Francesco Pennestri and Marco Raffaelli --Pathology /Gabriella Nesi and Raffaella Santi --Diagnosis and Clinical Pictures /Gabriele Parenti and Massimo Mannelli --Imaging /Massimo Falchini and Vittoria Rufini --Perioperative Management /Tommaso Borracci, Luca Vitali, Lorenzo Antonuzzo, Liliana Sollazzi and Valter Perilli, et al. --General Principles of Adrenal Surgery /Robin M. Cisco and Quan-Yang Duh --Instrumentation and High-Technology /Francesco Corcione, Valentina Brancato and Michele Giuseppe Iovino --Right Flank Trans-Abdominal Laparoscopic Adrenalectomy /Carlo Bergamini and Andrea Valeri --Left Flank Trans-Abdominal Laparoscopic Adrenalectomy /Celestino Pio Lombardi, Marco Raffaelli, Carmela De Crea, Francesco Pennestri and Rocco Bellantone --Posterior Retroperitoneoscopic Adrenalectomy /Rocco Bellantone, Marco Raffaelli, Carmela De Crea, Luigi Oragano and Celestino Pio Lombardi --Open Adrenalectomy /Giorgio De Toma, Andrea Polistena and Giuseppe Cavallaro --Other Techniques of Video-Assisted and Open Adrenalectomies /Rocco Bellantone, Francesco Corcione, Celestino Pio Lombardi, Marco Raffaelli and Carmela De Crea, et al. --Outcome of Adrenal Surgery /Andrea Valeri and Carlo Bergamini.
  • Imaging of endocrine and neuroendocrine tumors -- Fine needle aspiration cytology of endocrine tumors -- Fine needle aspiration cytology of neuroendocrine tumors arising in non-endocrine organs -- Tumors of the pituitary gland -- Tumors of thyroid gland : non-C cell tumors -- Tumors of the thyroid gland (C-cells) -- Tumors of parathyroid gland -- Tumors of the adrenal cortex -- Tumors of the adrenal medulla and extra-adrenal paraganglia -- Endocrine tumors of the lung and upper airways -- Neuroendocrine tumors of the pancreas -- Neuroendocrine tumors of the gastrointestinal tract -- Neuroendocrine tumours of the breast -- Neuroendocrine tumors of female genital tract -- Neuroendocrine tumors of prostate, urinary bladder, and kidney -- Neuroendocrine tumors of other miscellaneous sites : thymus and skin -- Endocrine tumors and tumor-like lesions of infancy, childhood, and adolescents and inherited tumor syndromes -- Application of molecular diagnosis techniques in the diagnosis and management of endocrine tumors.
  • Overview / Cindy L. Schwartz ... [et al.] -- Algorithms of late effects by disease / Cindy L. Schwartz, Wendy L. Hobbie, Louis S. constine -- Facilitating assessment of late effects by organ system / Cindy L. Schwartz, Wendy L. Hobbie, Louis S. Constine -- Central nervous system effects / Nina S. Kadan-Lottick, Joseph P. Neglia -- Neuroendocrine complications of cancer therapy / Wing Leung, Susan R. Rose, Thomas E. Merchant -- Ocular complications due to cancer treatment / Michael Ober, Camille A. Servodidio, David Abramson -- Head and neck / Arnold C. Paulino, Mary Koshy, Della Howell -- Adverse effects of cancer treatment on hearing / Wendy Landier, Thomas E. Merchant -- The thyroid gland / Tithi Biswas, Louis S. constine, Cindy L. Schwartz -- Cardiovascular effects of cancer therapy / M. Jacob Adams ... [et al.] --Pulmonary effects of antineoplastic therapy / Andrea S. Hinkle, Cindy Proukou, Yuhchyau Chen -- Late gastrointestinal and hepatic effects / M.M. Hudson -- The ovary / Debra L. Friedman -- The testes / Jill P. Ginsberg, Amit Maity -- Genitourinary / Lawrence Marks, Nicole Larrier -- Musculoskeletal, integument, breast / Robert B. Marcus, Jr. ... [et al.] -- Hematopoietic stem cell transplantation / Nancy Bunin, constance DiDomenico, Virginia Guzikowski -- Second malignancies following treatment for childhood cancer / Barbara Anne Hieb, Susan K. Ogle, Anna T. Meadows -- Psychological aspects of long-term survivorship / Mary T. Rourke, Anne E. Kazak -- Legal issues / Barbara Hoffman -- Methodological issues in the study of survivors of childhood cancer / Ann C. Mertens, Yutaka Yasui -- Transition issues / Kevin C. Oeffinger, Debra A. Eshelman.
  • T-cell lymphomas 2013, Springer
  • v. 2 Springer Protocols
    v. 1. Emerging strategies for targets and biomarker discovery -- v. 2. Emerging molecular targets and treatment options.
  • Targeted cancer therapy 2008, Springer
    Perspectives : bench to bedside and back / Jennifer Wheler and Razelle Kurzrock -- Targeted therapy in acute myelogenous leukemia / Elihu Estey -- Targeted therapy in breast cancer / Barbara S. Craft and Stacy Moulder -- Targeted therapy in chronic lymphocytic leukemia / Apostolia-Maria Tsimberidou and Michael J. Keating -- Targeted therapy in chronic myeloid leukemia / Elias Jabbour, Jorge Cortes, and Hagop Kantarjian -- Targeted therapy in colorectal cancer / Scott Kopetz -- Targeted therapy in non-small cell lung cancer / David J. Stewart -- Targeted therapy in lymphoma / Amanda Wedgwood and Anas Younes -- Targeted therapy in melanoma / Michael Davies, Sunil Patel, and Kevin B. Kim -- Targeted therapy in multiple myeloma / Yuhong Zhou, Raymond Alexanian, and Micael Wang -- Targeted therapy in myelodysplastic syndrome / Alfonso Quintás-Cardama ... [et al.] -- Targeted therapy in epithelial ovarian cancer / Maurie Markman -- Targeted drug therapy in pancreatic cancer / Don L. Gibbons, Robert A. Wolff, and Gauri Varadhachary -- Targeted therapy in prostate cancer / Amado J. Zurita, John F. Ward, and Jeri Kim -- Targeted therapy in renal cell carcinoma / Eric Jonasch and Nizar Tannir -- Targeted therapy of Sarcoma / Joseph Ludwig and Jonathan C. Trent -- Targeted and functional imaging / Vikas Kundra, Dawid Schellingerhout, and Edward F. Jackson -- Combining targeted therapies / David Hong and Lakshmi Chintala -- Drug development in cancer medicine : challenges for targeted approaches / Luis H. Camacho -- Toward personalized therapy for cancer / Sarah J. Welsh and Garth Powis.
  • Introduction: the rationale for the development of targeted drugs in cancer therapy -- Identifying critical signaling molecules for the treatment of cancer -- Tyrosine kinase inhibitors and cancer therapy -- Targeting ERBB receptors in cancer -- Inhibition of the IGF-I receptor for treatment of cancer. Kinase inhibitors and monoclonal anitbodies as alternative approaches -- Inhibition of the TGF-B signaling pathway in tumor cells -- The mammalian target of rapamycin kinase and tumor growth inhibtition -- The ras signalling pathway as a target in cancer therapy -- The mitogen-activated protein kinase pathway for molecular-targeted cancer treatment -- Clinical relevance of tareted interference with Src-mediated signal transduction events.
  • Targeted therapies 2011, Springer
    Resistance to Targeted Therapies As a Result of Mutation(s) in the Target / Alexis B. Cortot and Pasi A. Jänne -- The Dynamics of the Cell Signaling Network; Implications for Targeted Therapies / Daniel Gioeli -- Cancer Signaling Network Analysis by Quantitative Mass Spectrometry / Jason R. Neil and Forest M. White -- Development and Implementation of Array Technologies for Proteomics: Clinical Implications and Applications / Julia D. Wulfkuhle, Menawar Khalil, Joseph C. Watson, Lance A. Liotta and Emanuel F. Petricoin -- Using Phosphoflow® to Study Signaling Events of Subpopulations Resistant to Current Therapies / Omar D. Perez -- Mathematical and Computational Models in Cancer / Sudhir Chowbina, Kevin A. Janes, Shayn M. Peirce and Jason A. Papin -- Somatic Evolution of Acquired Drug Resistance in Cancer / John W. Pepper -- Interrogating Resistance to Targeted Therapy Using Genetically Engineered Mouse Models of Cancer / Edward Gunther -- microRNA: A Potential Therapy Able to Target Multiple Cancer Pathways / Benjamin Kefas and Benjamin W. Purow -- Rational Combination of Targeted Agents to Overcome Cancer Cell Resistance / Yun Dai and Steven Grant.
  • Telomerase inhibition 2007, Springer Protocols
    Methods of telomerase inhibition -- Telomerase inhibition by synthetic nucleic acids and chemosensitization in human bladder cancer cell lines -- hTERT knockdown in human embryonic kidney cells using double-stranded RNA -- RNA interference using a plasmid construct expressing a short-hairpin RNA -- Retrovirus-mediated RNA interference -- Telomerase inhibition and telomere targeting in hematopoietic cancer cell lines with small non-nucleosidic synthetic compounds (BIBR1532) -- Uses of telomerase peptides in anti-tumor immune therapy -- Establishing cell-based reporter systems for the analysis of hTERT expression -- Telomerase RNA inhibition using antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate -- Knockdown of telomerase RNA using hammerhead ribozymes and RNA interference -- Evaluation of tankyrase inhibition in whole cells -- Inhibition of telomerase by targeting MAP kinase signaling -- Screening of telomerase inhibitors -- Telomerase inhibition combined with other chemotherapeutic reagents to enhance anti-cancer effect.
  • "Therapeutic applications of quadruplex nucleic acids provides a single comprehensive survey that describes and assesses recent advances in quadruplex therapeutics and targeting strategies. It also covers the underlying fundamentals of such topics as quadruplex structure, small-molecule recognition, biological roles of genomic quadruplexes, and quadruplex informatics"--P. 4 of cover.
  • Thyroid cancer 2012, Springer
  • Thyroid cancer 2011, CRCnetBASE
    "Thyroid cancer evaluation and treatment has enjoyed very little evolution in comparison with other disease management strategies. The standard treatment algorithms for thyroid cancer have varied only in response to major, though infrequent, biotechnological innovations. These resultant algorithm node insertions produced paradigm changes, but there has been little to advance the care of the patient with advanced thyroid cancer--until very recently. Perhaps the reasons for a relative lack of interest and scientific progress are the overwhelming likelihood of benignity among thyroid nodules, the overwhelmingly favorable clinical outcome even if a patient has thyroid cancer, and the overwhelming long time required for clinical follow-up of these cancer patients. Unfortunately, the problem now is that we may be overmanaging low-risk patients, and we have not achieved the clinical responses we would have liked with high-risk patients"--Provided by publisher.
  • Thyroid cancer. 2nd ed. 2005, Springer
  • Thyroid cancer. 2nd ed. 2006, Springer
  • Thyroid neoplasms 2005, ScienceDirect
    Gene rearrangements in thryoid cancer -- Molecular markers of thyroid nodules -- Ultrasound in the diagnosis and management of thyroid cancer -- Controversies in the use of radioiodine for remnant ablation and therapy of thyroid carcinoma -- Thyroglobulin measurements in thryoid cancer evaluation and surveillance -- The role of fluoro-deoxy glucose (FDG) positron emission tomorgraphy (PET) in the management of differentiated thyroid cancer -- Preclinical studies of chemotherapy for undifferentiated thyroid carcinoma -- Medullary thyroid carcinoma -- Thyroid neoplasms in children and adolescents.
  • Phylogeny of the TRAF/math domain / Juan M. Zapata, Vanesa Martínez-García, and Sophie Lefebvre -- TRAF1 and its biological functions / Soo Young Lee and Yongwon Choi -- Physiological roles and mechanisms of signaling by TRAF2 and TRAF5 / Ping-Yee Billie Au and Wen-Chen Yeh -- TRAF3 and its biological function / Jeannie Q. He ... [et al.] -- TRAF4, the unique family member / Valérie Kedinger and Marie-Christine Rio -- Characteristics and biological functions of TRAF6 / Jun-ichiro Inoue, Jin Gohda and Taishin Akiyama -- Ubiquitination and TRAF signaling / Gabriel Pineda, Chee-Kwee Ea and Zhijian J. Chen -- Structural revelations of TRAF2 function in TNF receptor signaling pathway / Jee Y. Chung ... [et al.] -- Protein-protein interactions in TRAF3 / Kathryn R. Ely, Ramadurgam Kodandapani and ShuangDing Wu -- Molecular basis for the unique specificity of TRAF6 / Jee Y. Chung ... [et al.] --TRAF proteins in CD40 signaling / Gail A. Bishop ... [et al.] -- TRAFs in rank signaling / Bryant G. Darnay ... [et al.] -- The LT[beta]R signaling pathway / Paula S. Norris and Carl F. Ware -- LMP1 trafficking activates growth and survival pathways / Vishal Soni, Ellen Cahir-McFarland and Elliott Kieff -- Targeting TRAFs for therapeutic intervention / Juan M. Zapata, Sophie Lefebvre and John C. Reed.
  • TNM atlas. 5th ed. / 2004, Springer
  • v. 2 2008 Springer
    v. 1. Basic and clinical biology -- v. 2. Cancer treatment and therapy.
  • "With the advent of computer technology and medical imaging, treatment planning in radiation oncology has evolved from a way of devising beam arrangements to a sophisticated process whereby imaging scanners are used to define target volume, simulators are used to outline treatment volume, and computers are used to select optimal beam arrangements for treatment. As such, this book is designed to provide a comprehensive discussion of the clinical, physical, and technical aspects of treatment planning. The intent of Treatment Planning in Radiation Oncology is to review these methodologies and present a contemporary version of the treatment planning process"--Provided by publisher.
  • Tumeurs malignes rares 2010, Springer
  • Tumor ablation 2013, Springer
  • Tumor angiogenesis 2008, Springer
  • Tumor microenvironment 2010, Springer
  • The collection of chapters in this proceeding volume reflects the latest research presented at the Aegean meeting on Tumor Microenvironment and Cellular Stress held in Crete in Fall of 2012. The book provides critical insight to how the tumor microenvironment affects tumor metabolism, cell stemness, cell viability, genomic instability and more. Additional topics include identifying common pathways that are potential candidates for therapeutic intervention, which will stimulate collaboration between groups that are more focused on elucidation of biochemical aspects of stress biology and groups that study the pathophysiological aspects of stress pathways or engaged in drug discovery.
  • Perspectives on the history and evolution of tumor models -- Murine L1210 and P388 leukemias -- Transplantable syngeneic rodent tumors: solid tumors in mice -- B16 murine melanoma: historical perspective on the development of a solid tumor model -- Human tumor xenograft efficacy models -- Imaging the steps of metastasis at the macro and cellular level with fluorescent proteins in real time -- Patient-derived tumor models and explants -- The pediatric preclinical testing program -- Imaging efficacy in tumor models -- Mammary cancer in rats -- Animal models of melanoma -- Experimental animal models for investigating renal cell carcinoma pathogenesis and preclinical therapeutic approaches -- Animal models of mesothelioma -- The use of mouse models to study leukemia/lymphoma and assess therapeutic approaches -- Spontaneous companion animal (pet) cancers -- Genetically engineered mouse models of pancreatic ductal adenocarcinoma -- Transgenic adenocarcinoma of the mouse prostate: a validated model for the identification and characterization of molecular targets and the evaluation of therapeutic agents -- The utility of transgenic mouse models for cancer prevention research -- Models for evaluation of targeted therapies of invasive and metastatic disease -- Animal models of toxicities caused by anti-neoplastic therapy -- Bone marrow as a critical normal tissue that limits drug dose/exposure in preclinical models and the clinic -- Anesthetic considerations for the study of murine tumor models -- Preclinical tumor response end points -- Tumor cell survival -- Apoptosis in vivo -- Transparent window models and intravital microscopy: imaging gene expression, physiological function and therapeutic effects in tumors.
  • Tumor necrosis factor 2004, Springer Protocols
  • Tumor neurosurgery 2006, Springer
    I. Investigations -- Neurophysiology / Allen E. Waziri, Derek A. Taggard and Vincent C. Traynelis -- Neuroradiology and Ultrasound / David G. Hughes and Roger A. Chisholm -- Neuropathology / Cheng-Mei Shaw and Ellsworth C. Alvord -- II. Perioperative Care -- Neuroanesthesia / Maryke A. Kraayenbrink and Gregory R. McAnulty -- Neurosurgical Intensive Care / Tessa L. Whitton and Arthur M. Lam -- III. Techniques -- Neuroendoscopy / Jonathan Punt -- Principles and Practice of Image-guided Neurosurgery / Kristian Aquilina, Philip Edwards and Anthony Strong -- Stereotactic Radiosurgery / Andras A. Kemeny, Matthias W. R. Radatz and Jeremy G. Rowe -- IV. Tumors -- Low-grade Gliomasin Adults / Henry Marsh -- Neurosurgical Management of High-grade Gliomas / Robert C. Rostomily, Alexander M. Spence and Daniel L. Silbergeld -- Sellar and Parasellar Tumors / Richard J. Stacey and Michael P. Powell -- Meningiomas / James J. Evans, Joung H. Lee, John Suh and Mladen Golubic -- Intraventricular and Pineal Region Tumors / Sandeep Kunwar, G. Evren Keles and Mitchell S. Berger -- Cerebello-pontine Angle Tumors / Peter C. Whitfield and David G. Hardy -- Skull Base Tumors / Richard S. C. Kerr and Christopher A. Milford -- Tumors: Cerebral Metastases and Lymphoma / Sepideh Amin-Hanjani and Griffith R. Harsh -- Pediatric Neuro-oncology / Kevin L. Stevenson, J. Russell Geyer and Richard G. Ellenbogen -- Management of Spinal Tumors / Karl F. Kothbauer, George I. Jallo and Fred J. Epstein -- Management of Extradural Spinal Tumors / David A. Lundin, Charlie Kuntz and Christopher I. Shaffrey.
  • Lifestyle and Medical Approaches to Cancer Prevention / Peter Greenwald, p. 1-15 -- Application of Genetics to the Prevention of Colorectal Cancer / John Hopper, p. 17-33 -- Genetics and Prevention of Oesophageal Adenocarcinoma / Rebecca Fitzgerald, p. 35-46 -- Preclinical Models Relevant to Diet, Exercise, and Cancer Risk R. James Barnard and William Aronson, p. 47-62 -- Individualizing Interventions for Cancer Prevention / Michael Pollak, p. 63-70 -- Can Animal Models Help Us Select Specific Compounds for Cancer Prevention Trials? / Ernest Hawk, Asad Umar, Ronald Lubet, Levy Kopelovich and Jaye Viner, p. 71-88 -- Problems with Using Biomarkers as Surrogate End Points for Cancer: A Cautionary Tale / Arthur Schatzkin, p. 89-98 -- Can a Marker Be a Surrogate for Development of Cancer, and Would We Know It if It Exists? / William Armstrong, Thomas Taylor and Frank Meyskens, p. 99-112 -- How Should We Move the Field of Chemopreventive Agent Development Forward in a Productive Manner? / Frank Meyskens and Eva Szabo, p. 113-124 -- The Problems with Risk Selection; Scientific and Psychosocial Aspects / Anne-Renée Hartman, p. 125-144 -- Chemoprevention of Lung Cancer / Stéphane Vignot, Jean-Philippe Spano, Sylvie Lantuejoul, Fabrice André, Thierry Le Chevalier and Jean-Charles Soria, p. 145-165 -- Anti-nicotine Vaccination: Where Are We? / T. Cerny, p. 167-175 -- Primary Prevention of Colorectal Cancer: Lifestyle, Nutrition, Exercise / María Martínez, p. 177-211 -- Chemoprevention of Colorectal Cancer: Ready for Routine Use? / Nadir Arber and Bernard Levin, p. 213-230 -- Screening of Colorectal Cancer: Progress and Problems Sidney Winawer, p. 231-244 -- The Role of Endogenous Hormones in the Etiology and Prevention of Breast Cancer: The Epidemiological Evidence / Paola Muti, p. 245-256 -- Innovative Agents in Cancer Prevention / Margaret Manson, Peter Farmer, Andreas Gescher and William Steward, p. 257-275 -- The IARC Commitment to Cancer Prevention: The Example of Papillomavirus and Cervical Cancer / Silvia Franceschi, p. 277-297 -- Health Economics in the Genomic Age / Thomas Szucs, p. 299-313 -- Screening for Cancer: Are Resources Being Used Wisely? / Robert Kaplan, p. 315-334.
  • Tumor suppressor genes Springer Protocols
    v. 2 Springer Protocols
    v. 1 Pathways and isolation strategies -- v. 2 Regulation, function, and medicinal application.
  • During the last 20 years, it has become increasingly clear that the tumor micro-environment, the tumor stroma with its cellular end extracellular components, plays an crucial role in regulating tumor growth and progression. This book on 'Tumor-associated fibroblasts and their matrix' as part of the series on "Tumor-Microenvironment" is the first comprehensive discussion of these two main players of the tumor microenvironment. The best experts in this new area of tumor research and therapy review the role of these major components in the tumor stroma in the process of tumor developmen.
  • Tumors of the central nervous system v. 1-, 2011-, Springer
    Pt. 1. Astrocytomas : diagnosis and biomarkers -- pt. 2. Astrocytomas : therapy -- pt. 3. Astrocytomas : prognosis -- pt. 4. Hemangioblastoma -- pt. 5. Ganglioglioma -- pt. 6. Spinal Tumors (Part 1) -- pt. 7. Meningiomas and Schwannomas -- pt. 8. Astrocytoma, Medulloblastoma, Retinoblastoma, Chordoma, Craniopharyngioma, Oligodendroglioma, and Ependymoma.
  • v. 2, 2012 Springer
  • v. 4 Springer
  • The ninth volume in this essential series discusses key advances in our understanding of neoplasms in the human central nervous system. This publication deals with various aspects of nine separate types of brain tumors. With 70 contributors from 17 nations, this edition offers an unrivalled thoroughness and breadth of coverage that includes the very latest research results on the following tumor types: astrocytoma, lymphoma, supratentorial and glioneuronal tumors, gangliogliomas, neuroblastoma in adults, hemangioma, and ependymoma.The content introduces new technologies and their applications
  • Tumors of the chest 2006, Springer
  • Twenty years of G-CSF 2012, Springer
  • Two faces of evil 2011, Springer
    Homeostasis involves a delicate interplay between generative and degenerative processes to maintain a stable internal environment. In biological systems, equilibrium is established and controlled through a series of negative feedback mechanisms driven by a range of signal transduction processes. Failures in these complex communication pathways result in instability leading to disease. Cancer represents a state of imbalance caused by an excess of cell proliferation. In contrast, neurodegeneration is a consequence of excessive cell loss in the nervous system. Both of these disorders exhort profo
  • Urinary tract 2012, Springer
  • Urological cancers 2005, Springer
  • Urological oncology 2008, Springer
  • Uterine cancer 2009., Springer
    Essential epidemiology of cancer of the endometrium -- Endometrial cancer: screening, diagnosis, and surgical staging -- Imaging in the diagnosis and treatment of endometrial cancer -- Uterine cancer: pathology -- Molecular pathology and cytogenetics of endometrial carcinoma, carcinosarcoma, and uterine sarcomas -- Prognostic factors in uterine cancer -- Primary hormonal therapy of endometrial cancer -- Early-stage endometrial cancer: surgery -- Early-stage endometrial cancer: radiation -- Therapeutic modalities in early-stage uterine papillary serous carcinomas, carcinosarcomas, clear-cell and mixed histology carcinomas: building a case for combined chemotherapy and radiation -- Treatment of advanced and recurrent carcinoma: hormonal therapy -- Treatment of advanced and recurrent carcinoma: chemotherapy -- Treatment for advanced and recurrent carcinoma: combined modalities -- Management of uterine sarcomas -- Future directions: new targets.
  • Part 1. Pre-clinical development -- The Discovery and Characterisation of Tumour Endothelial Markers / Dario Neri and Roy Bicknell -- The Use of Animal Models in the Assessment of Tumour Vascular Disrupting Agents (VDAs) / R. Barbara Pedley and Gillian M. Tozer -- Combination Therapy with Chemotherapy and VDAs / Giulia Taraboletti, Katiuscia Bonezzi and Raffaella Giavazzi -- Lessons from Animal Imaging in Preclinical Models / Lesley D. McPhail and Simon P. Robinson -- Combining Antiangiogenic Drugs with Vascular Disrupting Agents Rationale and Mechanisms of Action / Yuval Shaked, Paul Nathan, Laura G. M. Daenen and Robert S. Kerbel -- Development of Vascular Disrupting Agents / Graeme J. Dougherty and David J. Chaplin -- Part 2. Imaging in the development of vascular disruptive agents -- MRI to Assess Vascular Disruptive Agents / Martin Zweifel and Anwar R. Padhani -- Contrast Ultrasound in Imaging Tumor Angiogenesis / Grzegorz Korpanty and Rolf A. Brekken -- Part 3. Clinical development -- The Clinical Development of Tubulin Binding Vascular Disrupting Agents / Martin Zweifel and Gordon Rustin -- ASA404 (DMXAA): New Concepts in Tumour Vascular Targeting Therapy / Bruce C. Baguley -- Vascular Disruptive Agents in Combination with Radiotherapy / Henry C. Mandeville and Peter J. Hoskin.
  • Cruciferous vegetables and biological activity of isothiocyanates and indoles -- Green leafy vegetables in cancer prevention -- The role of tomato lycopene in cancer prevention -- [Beta]-carotene and other carotenoids in cancer prevention -- The role of alliums and their sulfur and selenium constituents in cancer prevention -- Molecular mechanisms of chemoprevention with capsaicinoids for chili peppers -- Influence of dietary soy isoflavones genistein and daidzein on genotoxicity and mammary carcinogenicity in rats exposed to the model carcinogen 7, 12-dimethylbenz[a]anthracene (DMBA) -- The potential roles of seeds and seed bioactives on the prevention and treatment of breast and prostate cancer -- Nuts as part of a whole diet approach to cancer prevention -- Whole grains and their constituents in the prevention of colon cancer.
  • "This book presents a variety of vibrational spectroscopic techniques, focusing on Raman and Fourier transform infrared (FTIR) spectroscopy and their use in noninvasive optical tissue diagnosis. It covers the most recent research in this area to create a unique database of different chemical bands and their assignments of spectral bands. The text explores the spectroscopic investigation of different tissues and samples, including breast tissue, lung tissue, and brain tissue. Based on their years of experience with various applications, the authors provide definitions of peak frequencies as well as other aspects of spectroscopy that could be helpful to a wide range of scientists"--Provided by publisher.
  • Why we do CTC : screening for colorectal cancer / Richard M. Mendelson -- The performance of CTC / Didier Bielen -- Starting CT colonography in your department / Darra Murphy, Alan O'Hare, and Helen Fenlon -- The eligible patient : indications and contraindications / M. Raquel Oliva, Ayodale S. Odulate, and Koenraad J. Mortele -- Patient preparation for CT colonography / J. Yee -- The prerequisite : faecal tagging / Philippe Lefere and Stefaan Gryspeerdt -- How to get the colon distended? / David Burling, Stuart Taylor, and Steve Halligan -- Right parameters / Andrea Laghi -- How to interpret CTC data : evaluation of the different lesion morphologies / Beth G. McFarland -- How to avoid pitfalls in imaging : causes and solutions to overcome false-negatives and false-positives / Stefaan Gryspeerdt and Philippe Lefere -- 3D imaging : invaluable for the correct diagnosis? / Ayso H. De Vries and Jaap Stoker -- The challenge : detection of early-stage superficial colorectal lesions -- Gen Iinuma ... [et al.] -- Extracolonic findings / Francesca Turini, Francesca Cerri, and Emanuele Neri -- The future : computer-aided detection / H. Yoshida -- Quality and consistency in reporting CT colonography / Abraham H. Dachman, Piotr R. Obara, and Michael E. Zalis -- Virtual colonoscopy : beyond polyp detection? / T. Mang ... [et al.] -- Pictorial overview of normal anatomy, mimics of disease, and neoplasia using CT colonography / J.G. Fletcher, Fargol Booya, and Luis S. Guimaraes.
  • Vitamin D and cancer 2011, Springer
  • Negotiating personal and political settlements with breast cancer: women finding their own ways to live with human contingency / Rosemarie Tong -- Personalizing the political: negotiating the feminist, medical, scientific and commercial discourses surrounding breast cancer / Susan Sherwin -- Power, gender, and pizzazz: the early years of breast cancer activism / Barron Lerner -- Breast cancer: dueling discourses and the persistence of an outmoded paradigm / Gwynne Gertz -- Doing things with ideas and affects in the illness narratives of Susan Sontag and Eve Kosofsky Sedgwick / Lisa Diedrich -- The breast cancer diaries / Anita Ho -- Breast cancer: the maternal body reflected in a three-way mirror / Debra Gold -- Learn to love what's left: poems on breast cancer / Leatha Kendrick -- Death and the other: rethinking authenticity / Gail Weiss -- Breast cancer research: a political cause and paradigm for scientific inquiry / John S. Kovach -- Clinical trials for breast cancer and informed consent: how women helped make research a cooperative venture / Loretta M. Kopelman -- The role of psychosocial research in understanding and improving the experience of breast cancer and breast cancer risk / Anne Moyer and Marci Lobel -- Teaching about breast cancer and "common health" / Helen Rodnite Lemay -- Theoretical considerations on "reading" the breast / Tanfer Emin-Tunc -- Recent developments in breast cancer research / Sofya Maslyanskaya.
  • War on cancer 2005, Springer
  • Astrocytic Tumours -- Oligodendroglial Tumours -- Ependymal Tumours -- Choroid Plexus Tumours -- Other Neuroepithelial Tumours -- Neuronal and Mixed Neuronal- Glial Tumours -- Tumours of the Pineal Region -- Embryonal Tumours -- Tumours of the Cranial and Paraspinal Nerves -- Meningeal Tumours -- Tumours of the Haematopoietic System -- Germ Cell Tumours -- Familial Tumour Syndromes involving the Nervous System -- Tumours of the Sellar Region --Metastatic Tumours of the CNS.
  • Epidemiology / David Neary -- Economic burden / Richard J. Butler, William G. Johnson, and Timothy Gubler -- Employers' and survivors' perspectives / Ziv Amir, David R. Strauser, and Fong Chan -- Work disability : it is not just the "lesion" / Patrick Loisel -- The meaning of work / Guy Maytal and John Peteet -- Fatigue, pain, and physical function / Mary E. Sesto and Maureen J. Simmonds -- Cognitive limitations / Tracy Veramonti and Christina Meyers -- Young survivors of childhood cancer / Angela de Boer, Jos Verbeek, and Frank van Dijk -- Primary and occupational health care providers / Jos Verbeek, Angela de Boer, and Taina Taskila -- Rehabilitation / Michael J.L. Sullivan ... [et al.] -- Workplace accomodations / Fong Chan ... [et al.] -- Individuals with cancer in the workforce and their federal rights / Peter Blanck ... [et al.] -- International efforts : perspectives, policies, and programs / Patricia Findley and Catherine P. Wilson -- Future research, practice, and policy -- Michael Feuerstein.
  • From DNA replication to genome instability in schizosaccharomyces pombe: pathways to cancer /Julie M. Bailis and Susan L. Forsburg --Dissecting layers of mitotic regulation essential for maintaining genomic stability /Jeffiner S. Searle and Yolanda Sanchez --Yeast as a tool in cancer research: nuclear trafficking /Anita H. Corbett and Adam C. Berger --Studies of protein farnesylation in yeast /Nitika Thaper and Fuyuhiko Tamanoi --From bread to bedside: what budding yeast has taught us about the immortalization of cancer cells /Soma S.R. Banik and Christopher M. Counter --Hsp90 co-chaperones in saccharomyces cerevisiae /Marija Tesiccc and Richard F. Gaber --Yeast as a model system for studying cell cycle checkpoints /Carmela Palermo and Nancy C. Walworth --Metabolism and function of sphingolipids in saccharomyces cerevisiae: relevance to cancer research /L. Ashley Cowart, Yusuf A. Hannun, and Lina M. Obeid --Exploring and restoring the p53 pathway using the p53 dissociator assay in yeast /Rainer K. Brachmann --Functional analysis of the Human p53 tumor suppressor and its mutants using yeast /Alberto Inga, Francesca Storici and Michael A. Resnick --ABC transporters in yeast - drug resistance and stress response in a nutshell /Karl Kuchler and Christoph Schüller --The FHCRC/NCI yeast anticancer drug screen /Susan L. Holbeck and Julian Simon --Yeast as a model to study the immunosuppressive and chemotherapeutic drug rapamycin /John R. Rohde, Sara A. Zurita-Martinez, and Maria E. Cardenas --Use of yeast as a model of system for identifying and studying anti-cancer drugs /Jun O. Liu and Julian A. Simon --Genetic analysis of cisplatin resistance in yeast and mammals /Seiko Ishida and Ira Herskowitz --Using yeast tools to dissect the action of anti-cancer drugs: mechanisms of enzyme inhibition and cell killing: agents targeting DNA topoisomerases /Anna Rogojina, ... [et al].

Shortcut to Licensed Content

Lane Gateway to Licensed Content

  • Select "Add to Favorites" (click “Continue” if you see a security alert)
  • From the "Create in" menu, select “Links” (IE7) or “Favorites Bar” (IE8, IE9) to install

Shortcut for iPhone

Lane Gateway to Licensed Content

  • Drag this button to your Safari bookmarks bar
  • Open iTunes and sync your iPhone; make sure "Sync Safari Bookmarks" under iPhone Info tab is selected
  • To invoke the bookmarklet on your iPhone, open Safari and tap the "Bookmarks" icon
  • Tap "Bookmarks Bar"
  • Tap "Lane Proxy Bookmarklet"

What is it?

This shortcut (Lane proxy bookmarklet) gives you access to resources licensed by the library even when you're not coming from a Lane or a Stanford IP address.

While we'd like Lane to be your gateway to our licensed content, we recognize that links to books, articles and journals come from a variety of different sources (Google, your email, RSS reader, etc.).

Lane Proxy Bookmarklet in the Bookmarks Bar
Up arrow

When installed, it will look your browser bookmark.

At the page you would like to proxy, click the "Lane Gateway to Licensed Content" to invoke it.

If Lane licenses that content, you'll get access as if you were on campus.

How does it work?

This shortcut (Lane proxy bookmarklet) is a combination of a browser bookmark and a JavaScript application. In other words, it's a bookmark that can be programmed to do things. The Lane proxy bookmarklet simply prepends the Lane proxy URL to the current URL in your browser.

This allows you to view the URL as though you were on campus, giving you access to materials licensed for use by the Stanford academic community.

If you're not authenticated, you'll be prompted for your SUNetID and password.

Don't see the Toolbar, Bookmarks, or Links or Favorites bar?

FireFox

From the "View" menu, select "Toolbars" & choose "Bookmarks Toolbar"

 

Safari

From the "View" menu, choose "Show Bookmarks Bar"

 

Chrome

From the "View" menu, choose "Always Show Bookmarks Bar"

 

Internet Explorer

IE controller bar
  • Right-click in a clear area near the browser address bar
  • In the menu, check a box next "Links" (IE7) or "Favorites" (IE8, IE9)
  • Managing IE Favorites

Caveats

This shortcut (Lane proxy bookmarklet) only works with resources Lane has licensed and configured to work with our proxy server.

If invoked on a resource we do not license and/or have not yet configured, you will see an error message:

The Lane proxy server cannot complete your request because this host has not been configured properly.

We make no attempt to configure our proxy server for every resource, only those we license and for which a Stanford IP address grants access.

Drag this button onto your browser toolbar to install.

  • Right click this button
  • Select "Add to Favorites", click "Continue" if you see a security alert
  • In "Create in" menu, select "Links" (IE7) or "Favorites Bar" (IE8, IE9) to install

Drag this button onto Safari Bookmarks bar to install.

There are 120 high level MeSH Subject Headings under which all MeSH terms fall. Choose a subject heading to see the journals Lane offers in that subject area.

 

NEW BOOK

New Book

Edited by Thomas A. Fleisher, Anthony J. Frew, Robert R. Rich, Harry W. Schroeder, Jr., William T. Shearer, Cornelia M. Weyand

Largest, broadest eBook package; covers all sciences, as well as technology (including software), medicine, and humanities. In addition to covering Wiley and Springer, MyiLibrary is also the only provider for Oxford and Cambridge University Press titles. No seat restrictions.Largest, broadest eBook package; covers all sciences, as well as technology (including software), medicine, and humanities. In addition to covering Wiley and Springer, MyiLibrary is also the only provider for Oxford and Cambridge University Press titles. No seat restrictions.Large number of high quality software and database programming titles from O'Reilly. Other software titles are also available from Sams and Prentice Hall. Limited to 7 concurrent users.Vast collection of software and database programming titles from multiple publishers, including Microsoft Press.Largest provider of engineering-related eBooks; includes titles in computer science and biomedical engineering.Over 4,000 full-text e-books covering scientific and technical information from CRC Press and others. Many handbooks and single volume reference sources.A repository of medical knowledge from internal medicine, cardiology, genetics, pharmacy, diagnosis and management, basic sciences, patient care, and more. Continuously expanding, all databases in the repository contain the latest editions of selected medical titles.Includes peer-reviewed life science and biomedical research protocols compiled from Methods in Molecular Biology, Methods in Molecular Medicine, Methods in Biotechnology, Methods in Pharmacology and Toxicology, Neuromethods, the Biomethods Handbook, the Proteomics Handbook, and Springer Laboratory Manuals.Contains full text access to selected biomedical and nursing books.Provides one-click access to important clinical resources; includes evidence-based diagnosis and treatment guidelines, Books, EBM articles, Ovid MEDLINE, Drug facts and comparisons, Drug interaction facts, guidelines from National Guideline Clearinghouse, patient handouts (English and Spanish), and local content.MD consult provides access to textbooks, electronic journals, practice guidelines, drug information, and patient education handouts.A collection of biomedical books that can be searched directly by concept, and linked to terms in PubMed abstracts.Provides online, full-text access to Springer's journal titles as well as journals from other publishers. Subjects include: life sciences, chemical sciences, environmental sciences, geosciences, computer science, mathematics, medicine, physics and astronomy, engineering and economics. Also includes eBooks.Collection of over 8 thousand fulltext titles in engineering, math, and basic and applied biomedical research. Coverage is from 1967 to the present.A library of ebooks on a wide array of topics, digitized and made available online in conjunction with the original publishers.
School of Medicine